UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q



þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2017



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-4858

INTERNATIONAL FLAVORS &

FRAGRANCES INC.

(Exact name of registrant as specified in its charter)




New York		13-1432060
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

521 West 57th Street, New York, N.Y. 10019-2960

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (212) 765-5500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.



Large accelerated filer	þ	Accelerated filer	¨

Non-accelerated filer	¨	Smaller reporting company	¨
		Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

Number of shares outstanding as of ~~July~~October 24, 2017: ~~78,975,735~~78,977,158

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

INTERNATIONAL FLAVORS & FRAGRANCES INC.

CONSOLIDATED BALANCE SHEET

(DOLLARS IN THOUSANDS)

(Unaudited)


	June 30, 2017			December 31, 2016			September 30, 2017			December 31, 2016
ASSETS
Current Assets:
Cash and cash equivalents	$	491,386		$	323,992		$	316,002		$	323,992
Trade receivables (net of allowances of $12,772 and $9,995, respectively)	665,511			550,658
Trade receivables (net of allowances of $14,258 and $9,995, respectively)							691,239			550,658
Inventories: Raw materials	309,544			288,629			303,296			288,629
Work in process	17,828			13,792			15,724			13,792
Finished goods	296,390			289,596			300,496			289,596
Total Inventories	623,762			592,017			619,516			592,017
Prepaid expenses and other current assets	213,267			142,347			222,990			142,347
Total Current Assets	1,993,926			1,609,014			1,849,747			1,609,014
Property, plant and equipment, at cost	2,022,866			1,913,333			2,073,149			1,913,333
Accumulated depreciation	(1,211,040		)	(1,137,617		)	(1,244,557		)	(1,137,617		)
	811,826			775,716			828,592			775,716
Goodwill	1,145,165			1,000,123			1,153,619			1,000,123
Other intangible assets, net	426,064			365,783			424,138			365,783
Deferred income taxes	150,359			138,636			158,094			138,636
Other assets	91,535			127,712			106,248			127,712
Total Assets	$	4,618,875		$	4,016,984		$	4,520,438		$	4,016,984
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Bank borrowings and overdrafts and current portion of long-term debt	$	257,873		$	258,516		$	7,888		$	258,516
Commercial paper							39,957			—
Accounts payable	265,900			274,815			271,194			274,815
Accrued payroll and bonus	53,833			64,357			74,488			64,357
Dividends payable	50,621			50,678			54,440			50,678
Other current liabilities	232,996			249,931			248,160			249,931
Total Current Liabilities	861,223			898,297			696,127			898,297
Long-term debt	1,636,338			1,066,855			1,625,502			1,066,855
Deferred gains	38,529			39,816			37,975			39,816
Retirement liabilities	251,154			243,407			241,563			243,407
Other liabilities	151,545			137,475			156,783			137,475
Total Other Liabilities	2,077,566			1,487,553			2,061,823			1,487,553
Commitments and Contingencies (Note 13)
Shareholders’ Equity:
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,858,190 shares as of June 30, 2017 and December 31, 2016 and outstanding 78,975,563 and 79,213,037 shares as of June 30, 2017 and December 31, 2016	14,470			14,470
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,858,190 shares as of September 30, 2017 and December 31, 2016 and outstanding 78,977,158 and 79,213,037 shares as of September 30, 2017 and December 31, 2016							14,470			14,470
Capital in excess of par value	148,445			152,481			155,843			152,481
Retained earnings	3,909,200			3,818,535			3,965,133			3,818,535
Accumulated other comprehensive loss	(676,201		)	(680,095		)	(656,651		)	(680,095		)
Treasury stock, at cost - 36,882,627 shares as of June 30, 2017 and 36,645,153 shares as of December 31, 2016	(1,721,556		)	(1,679,147		)
Treasury stock, at cost - 36,881,032 shares as of September 30, 2017 and 36,645,153 shares as of December 31, 2016							(1,721,482		)	(1,679,147		)
Total Shareholders’ Equity	1,674,358			1,626,244			1,757,313			1,626,244
Noncontrolling interest	5,728			4,890			5,175			4,890
Total Shareholders’ Equity including noncontrolling interest	1,680,086			1,631,134			1,762,488			1,631,134
Total Liabilities and Shareholders’ Equity	$	4,618,875		$	4,016,984		$	4,520,438		$	4,016,984

See Notes to Consolidated Financial Statements

INTERNATIONAL FLAVORS & FRAGRANCES INC.

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(AMOUNT IN THOUSANDS EXCEPT PER SHARE AMOUNTS)

(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016			2017			2016			2017			2016
Net sales	$	842,861		$	793,478		$	1,671,154		$	1,576,789		$	872,940		$	777,001		$	2,544,094		$	2,353,790
Cost of goods sold	468,272			427,837			931,899			850,940			490,884			430,733			1,422,783			1,281,673
Gross profit	374,589			365,641			739,255			725,849			382,056			346,268			1,121,311			1,072,117
Research and development expenses	70,320			63,252			140,031			126,637			70,932			64,415			210,963			191,052
Selling and administrative expenses	135,910			132,784			276,240			256,327			141,473			152,046			417,713			408,372
Amortization of acquisition-related intangibles	8,494			5,130			15,561			11,191			8,766			5,468			24,327			16,659
Restructuring and other charges, net	791			—			10,934			—			3,249			—			14,183			—
Gain on sales of fixed assets	(68		)	(197		)	(89		)	(2,910		)	(31		)	(87		)	(120		)	(2,998		)
Operating profit	159,142			164,672			296,578			334,604			157,667			124,426			454,245			459,032
Interest expense	17,556			15,060			30,363			27,539			19,221			13,111			49,584			40,649
Other (income) expense, net	(454		)	(2,438		)	(14,312		)	118			(2,880		)	(2,075		)	(17,192		)	(1,954		)
Income before taxes	142,040			152,050			280,527			306,947			141,326			113,390			421,853			420,337
Taxes on income	32,245			35,317			54,968			71,610			31,065			23,613			86,033			95,223
Net income	109,795			116,733			225,559			235,337			110,261			89,777			335,820			325,114
Other comprehensive income (loss), after tax:
Foreign currency translation adjustments	13,347			(4,689		)	10,090			9,389			19,719			(6,191		)	29,809			3,198
(Losses) gains on derivatives qualifying as hedges	(11,768		)	800			(13,519		)	(9,392		)	(4,014		)	268			(17,533		)	(9,124		)
Pension and postretirement net liability	3,688			2,578			7,323			5,133			3,845			2,586			11,168			7,719
Other comprehensive income (loss)	5,267			(1,311		)	3,894			5,130			19,550			(3,337		)	23,444			1,793
Total comprehensive income	$	115,062		$	115,422		$	229,453		$	240,467		$	129,811		$	86,440		$	359,264		$	326,907

Net income per share - basic	$	1.39		$	1.46		$	2.85		$	2.94		$	1.39		$	1.13		$	4.24		$	4.07
Net income per share - diluted	$	1.38		$	1.46		$	2.84		$	2.93		$	1.39		$	1.12		$	4.22		$	4.05
Average number of shares outstanding - basic	79,072			79,764			79,088			79,809			79,063			79,580			79,072			79,727
Average number of shares outstanding - diluted	79,305			80,040			79,360			80,141			79,362			79,935			79,353			80,067
Dividends declared per share	$	0.64		$	0.56		$	1.28		$	1.12		$	0.69		$	0.64		$	1.97		$	1.76

See Notes to Consolidated Financial Statements

INTERNATIONAL FLAVORS & FRAGRANCES INC.

CONSOLIDATED STATEMENT OF CASH FLOWS

(DOLLARS IN THOUSANDS)

(Unaudited)


	Six Months Ended June 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Cash flows from operating activities:
Net income	$	225,559		$	235,337		$	335,820		$	325,114
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization	55,805			49,743			85,446			75,109
Deferred income taxes	1,505			16,543			(3,439		)	8,323
Gain on disposal of assets	(89		)	(2,910		)	(120		)	(2,998		)
Stock-based compensation	12,893			13,774			20,149			19,471
Pension contributions	(31,557		)	(39,510		)	(36,870		)	(44,356		)
Litigation settlement	(56,000		)	—			(56,000		)	—
Foreign currency gain on liquidation of entity	(12,214		)	—			(12,214		)	—
Changes in assets and liabilities, net of acquisitions:
Trade receivables	(77,580		)	(70,361		)	(94,945		)	(36,070		)
Inventories	(4,228		)	(7,271		)	6,211			(160		)
Accounts payable	(23,479		)	(29,167		)	(20,560		)	(29,523		)
Accruals for incentive compensation	(12,316		)	(2,001		)	2,907			3,012
Other current payables and accrued expenses	(3,099		)	13,400			9,423			30,663
Other assets	18,007			4,054			3,824			(10,704		)
Other liabilities	(35,286		)	(9,335		)	(40,143		)	3,956
Net cash provided by operating activities	57,921			172,296			199,489			341,837
Cash flows from investing activities:
Cash paid for acquisitions, net of cash received	(191,304		)	—			(191,304		)	—
Additions to property, plant and equipment	(46,153		)	(43,236		)	(77,318		)	(70,179		)
Proceeds from life insurance contracts	1,941			—			1,941			292
Maturity of net investment hedges	3,016			(641		)	2,226			(12		)
Proceeds from disposal of assets	473			3,630			1,275			3,664
Net cash used in investing activities	(232,027		)	(40,247		)	(263,180		)	(66,235		)
Cash flows from financing activities:
Cash dividends paid to shareholders	(101,184		)	(89,463		)	(151,678		)	(134,051		)
Increase (decrease) in revolving credit facility borrowings and overdrafts	21,595			(138,142		)
Decrease in revolving credit facility borrowings and overdrafts							(3,952		)	(128,324		)
Increase in commercial paper							39,950			—
Deferred financing costs	(5,373		)	(4,796		)	(5,373		)	(4,780		)
Repayments of debt							(250,000		)	(125,000		)
Proceeds from issuance of long-term debt	498,250			555,559			498,250			555,559
Loss on pre-issuance hedges	(5,310		)	(3,244		)	(5,310		)	(3,244		)
Proceeds from issuance of stock under stock plans	329			494			329			594
Employee withholding taxes paid	(11,485		)	(13,315		)	(11,509		)	(13,315		)
Purchase of treasury stock	(53,211		)	(71,714		)	(53,211		)	(94,148		)
Net cash provided by financing activities	343,611			235,379			57,496			53,291
Effect of exchange rate changes on cash and cash equivalents	(2,111		)	(9,424		)	(1,795		)	(12,151		)
Net change in cash and cash equivalents	167,394			358,004			(7,990		)	316,742
Cash and cash equivalents at beginning of year	323,992			181,988			323,992			181,988
Cash and cash equivalents at end of period	$	491,386		$	539,992		$	316,002		$	498,730
Interest paid, net of amounts capitalized	$	21,817		$	24,971		$	38,634		$	45,008
Income taxes paid	$	50,962		$	52,719		$	77,356		$	80,050

See Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements

Note 1. Consolidated Financial Statements:

Basis of Presentation

These interim statements and related management’s discussion and analysis should be read in conjunction with the Consolidated Financial Statements and the related notes and management’s discussion and analysis of results of operations, liquidity and capital resources included in our 2016 Annual Report on Form 10-K (“2016 Form 10-K”). These interim statements are unaudited. The year-end balance sheet data included in this Form 10-Q was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America. We have historically operated and continue to operate on a 52/53 week fiscal year ending on the Friday closest to the last day of the quarter. For ease of presentation, ~~June~~September 30 and December 31 are used consistently throughout this Form 10-Q and these interim financial statements and related notes to represent the period-end dates. For the 2017 and 2016 quarters, the actual closing dates were ~~June~~September 29, and September 30, ~~and July 1,~~ respectively. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented. When used herein, the terms “IFF,” the “Company,” “we,” “us” and “our” mean International Flavors & Fragrances Inc. and its consolidated subsidiaries.

Reclassifications and Revisions

Certain prior year amounts have been reclassified and revised to conform with current year presentation.

The Consolidated Statement of Comprehensive Income has been revised to properly reflect Gain on sales of fixed assets within Operating profit for the three and ~~six~~nine months ending ~~June~~September 30, 2016. These amounts were previously included in Other (income) expense, net. The Consolidated Statement of Cash Flows has been revised to properly reclassify $5.4 million from Other current payables to Other assets for the six months ending June 30, 2016. This adjustment had no impact on Net cash provided from operating activities. In addition, approximately $5.4 million of expense was recorded during the first quarter of 2017 for a tax assessment relating to prior periods. The Consolidated Statement of Cash Flows has been revised to properly reclassify $5.4 million from Net cash used in financing activities to Net cash provided by operating activities for the nine months ended September 30, 2016. These adjustments were not material to the current and previously-issued financial statements.

Recent Accounting Pronouncements

In ~~May~~August 2017, the Financial Accounting Standards Board (“FASB”) issued amendments to the Derivatives and Hedging guidance which eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. This guidance is effective for fiscal years beginning after December 15, 2018. Early adoption is permitted. The amended presentation and disclosure requirements should be applied prospectively while the amendments to cash flow and net investment hedge relationships should be applied on a modified retrospective basis. The Company is currently evaluating the impact this guidance will have on its Consolidated Financial Statements.

In May 2017, the FASB issued amendments to the Compensation - Stock Compensation guidance which clarifies ~~which~~ changes to the terms or conditions of a share-based payment award that require an entity to apply modification accounting. This guidance is effective, and should be applied prospectively, for fiscal years beginning after December 15, 2017. Early adoption is permitted. The Company does not expect this guidance to have an impact on its Consolidated Financial Statements as it is not the Company's practice to modify the terms or conditions of a share-based payment award after it has been granted.

In March 2017, the FASB issued amendments to the Compensation - Retirement Benefits guidance which requires employers that present a measure of operating income in their statement of income to include only the service cost component of net periodic pension cost and postretirement costs in operating expenses. This guidance is effective, and should be applied ~~retroactively,~~retrospectively, for fiscal years beginning after December 15, 2017. Early adoption is permitted as of the beginning of an annual period. The Company expects the impact that this guidance will have on its Consolidated Statement of Comprehensive Income will be an increase in operating expenses of approximately $15 million and $30 million for the fiscal years 2016 and 2017, respectively. There will be no impact to Net income in either period.

In January 2017, the FASB issued amendments to the Business Combination guidance which clarifies the definition of a business in order to assist companies when evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. This guidance will be effective prospectively for annual and interim periods beginning after December 15, 2017. The Company is currently evaluating the impact this guidance may have on its consolidated financial statements and on accounting for future acquisitions.

In January 2017, the FASB issued an amendment to the Goodwill Impairment guidance which eliminates Step 2 from the goodwill impairment test. This guidance will be effective for fiscal years beginning after December 15, 2019. Early adoption is ~~permitted. The~~permitted and the Company ~~plans~~has elected to early adopt this guidance ~~in accordance with~~and will apply it to its existing annual impairment review policy infor fiscal year 2017. The Company does not expect this adoption to have an impact on its consolidated financial statements.

In October 2016, the FASB issued authoritative guidance which allows for the immediate recognition of current and deferred income tax impact on intra-entity asset transfers, excluding inventory. This guidance will be effective for fiscal years beginning after December 15, 2017. The Company adopted this guidance in the first quarter of fiscal year 2017 and accordingly, recorded a cumulative-effect adjustment to Retained earnings that reduced Other assets and adjusted Deferred income taxes by a net amount of approximately $33 million.

In August 2016, the FASB issued authoritative guidance which requires changes to the classification of certain activities within the statement of cash flows. This guidance will be effective for annual and interim periods beginning after December 15, 2017. Early adoption will be permitted for all entities. The Company does not expect this adoption to have a significant impact on its Consolidated Statement of Cash Flows.

In March 2016, the FASB issued authoritative guidance which requires changes to several aspects of the accounting for share-based payment transactions, including the treatment of income tax consequences, classification of awards as either equity or liabilities, and classification of certain items on the statement of cash flows. This guidance was effective for annual and interim periods beginning after December 15, 2016. The Company adopted this standard during the first quarter of 2017. The standard requires that employee taxes paid when an employer withholds shares be presented in the Consolidated Statement of Cash Flows as a financing activity instead of an operating activity. The Company adopted this change ~~retrospectively, resulting~~retrospectively. The adoption resulted in a $11.5 million and $13.3 million ~~increase~~reclassification from Net cash provided by operating activities to Net cash provided by ~~operating~~financing activities on the Consolidated Statement of Cash Flows as of ~~June~~September 30, 2017 and 2016, respectively. In addition, the standard requires that excess tax benefits presented in the Consolidated Statement of Cash Flows be classified as an operating activity instead of a financing activity. The Company adopted this change ~~retrospectively, resulting~~retrospectively. The adoption resulted in a $3.2 million and ~~$4.4~~$4.5 million ~~increase~~reclassification from Net cash provided by financing activities to Net cash provided by operating activities on the Consolidated Statement of Cash Flows as of ~~June~~September 30, 2017 and 2016, respectively.

The standard also requires all excess tax benefits/deficiencies be recognized as income tax expense/benefit in the Consolidated Statement of Comprehensive Income. This guidance has been applied prospectively. This change resulted in a $3.2 million benefit to income tax expense for the period ended ~~June~~September 30, 2017. The 2016 period included a ~~$4.2~~$1.2 million benefit to equity, which has not been retrospectively adjusted. The full year 2016 benefit to equity was $5.3 million. Additionally, the standard allows the Company to make an entity-wide accounting policy election to either estimate the number of awards that are expected to be forfeited or account for forfeitures as they occur. The Company has elected to continue to account for forfeitures using an estimate of awards expected to be forfeited.

In February 2016, the FASB issued authoritative guidance which requires changes to the accounting for leases. The new guidance establishes a new lease accounting model, that requires entities to record assets and liabilities related to leases on the balance sheet for certain types of leases. The guidance will be effective for annual and interim periods beginning after December ~~31,~~15, 2018. Early adoption will be permitted for all entities. The Company expects the adoption of this guidance will result in significant increases to assets and liabilities on its Consolidated Balance Sheet and is still evaluating the impact on its Consolidated Statement of Comprehensive Income.

In May 2014, the FASB issued authoritative guidance that provides for a comprehensive model to be used in accounting for revenue arising from contracts with customers. Under this standard, revenue will be recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. This guidance is applicable to all entities and is effective for annual and interim periods beginning after December 15, 2017. Companies have the option to apply the new guidance under a retrospective approach to each prior reporting period presented or a modified retrospective approach with the cumulative effect of initially applying the new guidance recognized at the date of initial application within the Consolidated Balance Sheet. The Company has determined that it will adopt this guidance using the modified retrospective approach. The Company is evaluating the impact of the new standard, including updates to the standard that were issued by the FASB. In particular, the Company has reviewed the nature of its larger customer relationships and is in the process of reviewing the nature of potential regional variations in all aspects of its customer base regardless of size. Based on the work performed to date, the Company expects to conduct further review and analysis of certain areas that may lead to changes in the manner in which the Company recognizes revenue, including the customized nature of the product, consignment arrangements, rebates, upfront costs, shipping terms and documentation other than formal contracts. As a result, the financial statement impact has not yet been determined. The Company ~~is also currently evaluating the method of adoption and~~continues to evaluate the potential ~~impacts to~~impact of this standard on its consolidated financial statements and related disclosures.

Accounts Receivable

The Company sells certain accounts receivable on a non-recourse basis to unrelated financial institutions under “factoring” agreements that are sponsored, solely and individually, by certain customers. The Company accounts for these transactions as sales of receivables, removes the receivables sold from its financial statements, and records cash proceeds when received by the Company. The beneficial impact on cash provided by operations from participating in these programs ~~decreased~~

increased approximately ~~$4.7~~$12.1 million for the ~~six~~nine months ended ~~June~~September 30, 2017 compared to an increase of approximately ~~$17.7~~$25.8 million for the ~~six~~nine months ended ~~June~~September 30, 2016. The cost of participating in these programs was immaterial to our results in all periods.

Currency Translation Adjustment Reclassification

During the first quarter of 2017, the Company recorded income of approximately $12.2 million related to a foreign currency exchange gain from the release of a currency translation adjustment upon the liquidation of a foreign entity in 2017. This amount was recorded to Other (income) expense, net.

Note 2. Net Income Per Share:

Net income per share is based on the weighted average number of shares outstanding. A reconciliation of the shares used in the computation of basic and diluted net income per share is as follows:


	Three Months Ended June 30,		Six Months Ended June 30,		Three Months Ended September 30,		Nine Months Ended September 30,
(SHARES IN THOUSANDS)	2017	2016	2017	2016	2017	2016	2017	2016
Basic	79,072	79,764	79,088	79,809	79,063	79,580	79,072	79,727
Assumed dilution under stock plans	233	276	272	332	299	355	281	340
Diluted	79,305	80,040	79,360	80,141	79,362	79,935	79,353	80,067

There were no stock options or stock-settled appreciation rights (“SSARs”) excluded from the computation of diluted net income per share for the three and ~~six~~nine months ended ~~June~~September 30, 2017. An immaterial amount of SSARs were excluded from the 2016 period.

The Company has issued shares of purchased restricted common stock and purchased restricted common stock units (collectively “PRSUs”) which contain rights to nonforfeitable dividends while these shares are outstanding and thus are considered participating securities. Such securities are required to be included in the computation of basic and diluted earnings per share pursuant to the two-class method. The Company did not present the two-class method since the difference between basic and diluted net income per share for both unrestricted common shareholders and PRSU shareholders was less than $0.01 per share for each period presented, and the number of PRSUs outstanding as of ~~June~~September 30, 2017 and 2016 was immaterial. Net income allocated to such PRSUs was $0.2 million ~~and $0.3 million~~ for both the three months ended ~~June~~September 30, 2017 and 2016~~, respectively~~ and ~~$0.5~~was $0.7 million ~~during each of~~and $0.8 million for the ~~six~~nine months ended ~~June~~September 30, 2017 and ~~2016.~~2016, respectively.

Note 3. Acquisitions:

2017 Activity

PowderPure

On April 7, 2017, the Company completed the acquisition of 100% of the outstanding shares of Columbia PhytoTechnology, LLC d/b/a PowderPure ("PowderPure"), a privately-held flavors company with facilities in North America. The acquisition was accounted for under the purchase method. PowderPure was acquired to expand expertise in, and product offerings of, clean label solutions within the Flavors business. The Company paid approximately $55 million including $0.3 million of cash acquired for this acquisition, which was funded from existing resources including use of its revolving credit facility. Additionally, the Company recorded an accrual of approximately $1.4 million representing the current estimate of additional contingent consideration payable to the former owners of PowderPure. (The maximum earnout payable is $10 million upon satisfaction of certain performance metrics). The purchase price exceeded the preliminary fair value of existing net assets by approximately $46.7 million. The excess was allocated principally to identifiable intangible assets including approximately $27.5 million to proprietary technology, approximately $4.5 million to trade name and approximately $0.8 million to customer relationships, and approximately $13.9 million of goodwill (which is deductible for tax purposes). Goodwill is the excess of the purchase price over the fair value of net assets acquired and represents the value the Company expects to achieve from its increased exposure to clean label products within the Company's existing Flavors business. The intangible assets are being amortized over the following estimated useful lives: proprietary technology, 14 years, trade name, 14 years, and customer relationships, 4 years. The purchase price allocation is preliminary pending the finalization of the values of

intangible assets, finalization of working capital and the finalization of estimated useful lives. The purchase price allocation is expected to be completed by the fourth quarter of 2017.

No pro forma financial information for 2017 and 2016 is presented as the acquisition was not material to the consolidated financial statements.

Fragrance Resources

On January 17, 2017, the Company completed the acquisition of 100% of the outstanding shares of Fragrance Resources, a privately-held fragrance company with facilities in Germany, North America, France, and China. The acquisition was accounted for under the purchase method. Fragrance Resources was acquired to strengthen the North American and German Fragrances business. The Company paid approximately Euro 142.0 million (approximately $150.5 million) including approximately Euro 13.7 million (approximately $14.5 million) of cash acquired for this acquisition, which was funded from existing resources including use of its revolving credit facility. The purchase price exceeded the preliminary fair value of existing net assets by approximately $122.1 million. The excess was allocated principally to identifiable intangible assets including approximately $59.6 million related to customer relationships, approximately $6.1 million related to proprietary technology and trade name, and approximately $79.4 million of goodwill (which is not deductible for tax purposes) and approximately $23.0 million of net deferred tax liability. Goodwill is the excess of the purchase price over the fair value of net assets acquired and represents synergies from the addition of Fragrance Resources to the Company's existing Fragrances business. The intangible assets are being amortized over the following estimated useful lives: trade name, 2 years, proprietary technology, 5 years and customer relationships, 12 - 16 years. The purchase price allocation is preliminary pending the finalization of the values of intangible assets, principally customer relationships, finalization of working capital calculations and the finalization of estimated useful lives. The purchase price allocation is expected to be completed by the ~~third~~fourth quarter of 2017.

No pro forma financial information for 2017 and 2016 is presented as the acquisition was not material to the consolidated financial statements.

2016 Activity

David Michael

On October 7, 2016, the Company completed the acquisition of 100% of the outstanding shares of David Michael & Company, Inc. ("David Michael"). The acquisition was accounted for under the purchase method. David Michael was acquired to strengthen the North American flavors business. The Company paid approximately $242.6 million (including $5.1 million of cash acquired) for this acquisition, which was funded from existing resources. The preliminary purchase price allocation was updated during the first quarter of 2017, resulting in a reduction in allocation of value to customer relationships. The related reduction in amortization expense was not material to the Consolidated Statement of Comprehensive Income. The purchase price allocation was finalized during the second quarter of 2017. Additionally, during the second quarter of 2017, the Company finalized the working capital adjustment and paid an additional $0.6 million. The purchase price exceeded the fair value of existing net assets by approximately $168.7 million. The excess was allocated principally to identifiable intangible assets including approximately $50.0 million related to customer relationships, approximately $8.4 million related to proprietary technology and trade name, and approximately $110.2 million of goodwill (which is deductible for tax purposes). Goodwill is the excess of the purchase price over the fair value of net assets acquired and represents synergies from the addition of David Michael to the Company's existing Flavors business. The intangible assets are being amortized over the following estimated useful lives: trade name, 2 years, proprietary technology, 5 years and customer relationships, 18 - 20 years.

No pro forma financial information for 2016 is presented as the impact of the acquisition was immaterial to the Consolidated Statement of Comprehensive Income.

Note 4. Restructuring and Other Charges, Net:

2017 Productivity Program

On February 15, 2017, the Company announced that it was adopting a multi-year productivity program designed to improve overall financial performance, provide flexibility to invest in growth opportunities and drive long-term value creation. In connection with this program, the Company expects to optimize its global footprint and simplify its organizational structures globally. In connection with this initiative, the Company expects to incur cumulative, pre-tax cash charges of between $30-$35 million, consisting primarily of $21-$22 million in personnel-related costs and an estimated $9-$13 million in facility-related costs, such as lease termination, and integration-related costs. In addition, the Company may incur up to $5 million of accelerated depreciation.

The Company recorded ~~$10.1 million and $3.1~~$16.5 million of charges related to personnel-related costs and lease termination costs ~~during~~through the ~~first and second~~third quarter of 2017, ~~respectively,~~of which $3.2 million was recorded during the third quarter of 2017, with the remainder of the ~~personnel-related~~personnel-

related and other costs expected to be recognized by the end of ~~2017 and the other costs expected to be recognized over the following six quarters.~~2018. The Company made payments of ~~$2.1 million and $4.5~~$10.0 million related to severance in ~~the first and second quarters of 2017, respectively.~~2017. The overall charges were split approximately evenly between Flavors and Fragrances. This initiative is expected to result in the reduction of approximately 370 members of the Company’s global workforce, including acquired entities, in various parts of the organization.

2015 Severance Charges

During 2015, the Company established a series of initiatives intended to streamline its management structure, simplify decision-making and accountability, better leverage and align its capabilities across the organization and improve efficiency of its global manufacturing and operations network. As a result, the Company recorded charges for severance and related costs pertaining to approximately 150 positions that were affected. During ~~the first quarter of~~ 2017, the Company made payments of $0.2 million related to ~~severance. During the second quarter of 2017, the Company~~severance and recorded a credit of $2.3 million related to the reversal of severance accruals that were determined to be no longer required. No further actions are expected in 2017 related to these 2015 initiatives.

Changes in employee-related restructuring liabilities during the ~~six~~nine months ended ~~June~~September 30, 2017, were as follows:


(DOLLARS IN THOUSANDS)	Employee-Related Costs			Other			Total			Employee-Related Costs			Other			Total
Balance at December 31, 2016	$	3,277		$	—		$	3,277		$	3,277		$	—		$	3,277
Additional charges (reversals), net	9,984			950			10,934			13,233			950			14,183
Non-cash charges	—			(950		)	(950		)	—			(950		)	(950		)
Payments	(6,776		)	—			(6,776		)	(10,267		)	—			(10,267		)
Balance at June 30, 2017	$	6,485		$	—		$	6,485
Balance at September 30, 2017										$	6,243		$	—		$	6,243

Note 5. Goodwill and Other Intangible Assets, Net:

Goodwill

Movements in goodwill during 2017 were as follows:


(DOLLARS IN THOUSANDS)	Goodwill		Goodwill
Balance at December 31, 2016	$	1,000,123	$	1,000,123
Acquisitions	93,223		93,223
Foreign exchange	15,782		21,784
Other	36,037		38,489
Balance at June 30, 2017	$	1,145,165
Balance at September 30, 2017			$	1,153,619

Other above principally represents the increase to Goodwill associated with the update of certain customer relationship assumptions in the final purchase price allocation of David Michael, as disclosed in Note 3.

Other Intangible Assets

Other intangible assets, net consist of the following amounts:


	June 30,			December 31,			September 30,			December 31,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016
Cost
Customer relationships	$	407,612		$	371,270		$	414,045		$	371,270
Trade names & patents	37,817			30,679			38,503			30,679
Technological know-how	153,090			119,544			153,410			119,544
Other	24,692			24,470			24,777			24,470
Total carrying value	623,211			545,963			630,735			545,963
Accumulated Amortization
Customer relationships	(93,289		)	(82,555		)	(99,300		)	(82,555		)
Trade names & patents	(13,625		)	(12,198		)	(14,436		)	(12,198		)
Technological know-how	(71,404		)	(68,292		)	(73,289		)	(68,292		)
Other	(18,829		)	(17,135		)	(19,572		)	(17,135		)
Total accumulated amortization	(197,147		)	(180,180		)	(206,597		)	(180,180		)

Other intangible assets, net	$	426,064		$	365,783		$	424,138		$	365,783

Amortization

Amortization expense was $~~8.5~~8.8 million and ~~$5.1~~$5.5 million for the three months ended ~~June~~September 30, 2017 and 2016, respectively and ~~$15.6~~$24.3 million and ~~$11.2~~$16.7 million for the ~~six~~nine months ended ~~June~~September 30, 2017 and 2016, respectively. Annual amortization is expected to be ~~$34.5~~$35.6 million for the full year 2017, ~~$34.5~~$34.9 million for the year 2018, ~~$32.9~~$33.3 million for the year 2019, ~~$32.2~~$32.6 million for the year 2020, ~~$27.5~~$27.9 million for the year 2021 and ~~$25.1~~$25.5 million for the year 2022.

Note 6. Borrowings:

Debt consists of the following:


(DOLLARS IN THOUSANDS)	Rate		Maturities	June 30, 2017			December 31, 2016			Rate		Maturities	September 30, 2017			December 31, 2016
Senior notes - 2007 ⁽¹⁾	6.40	%	2017-27	499,735			499,676			6.55	%	2019-27	249,765			499,676
Senior notes - 2013 ⁽¹⁾	3.20	%	2023	298,519			297,986			3.20	%	2023	298,594			297,986
Euro Senior notes - 2016 ⁽¹⁾	1.75	%	2024	563,981			512,764			1.75	%	2024	582,514			512,764
Senior notes - 2017 ⁽¹⁾	4.38	%	2047	492,877			—			4.38	%	2047	492,653			—
Credit facility	1.13	%	2021	28,445			—
Commercial paper										1.191	%	2017	39,957			—
Bank overdrafts and other				10,275			13,599						9,807			13,599
Deferred realized gains on interest rate swaps				379			1,346						57			1,346
				1,894,211			1,325,371						1,673,347			1,325,371
Less: Current portion of debt				(257,873		)	(258,516		)				(47,845		)	(258,516		)
				$	1,636,338		$	1,066,855					$	1,625,502		$	1,066,855

⁽¹⁾ Amount is net of unamortized discount and debt issuance costs.

Senior Notes - 2017

On May 18, 2017, the Company issued $500.0 million face amount of 4.375% Senior Notes ("Senior Notes - 2017") due 2047 at a discount of $1.8 million. The Company received proceeds related to the issuance of these Senior Notes - 2017 of $493.9 million which was net of the $1.8 million discount and $4.4 million in underwriting fees (recorded as deferred financing costs). In addition, the Company incurred $0.9 million in legal and professional costs associated with the issuance and such costs were recorded as deferred financing costs. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $5.3 million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the 30 year term of the debt. The Senior Notes - 2017 bear interest at a rate of 4.375% per annum, with interest payable semi-annually on June 1 and December 1 of each year, commencing on December 1, 2017. The Senior Notes - 2017 will mature on June 1, 2047.

Upon 30 days’ notice to holders of the Senior Notes - 2017, the Company may redeem the Senior Notes - 2017 for cash in whole, at any time, or in part, from time to time, prior to maturity, at redemption prices that include accrued and unpaid interest and a make-whole premium, as specified in the Indenture governing the Senior Notes - 2017. However, no make-whole premium will be paid for redemptions of the Senior Notes - 2017 on or after December 1, 2046. The Indenture provides for customary events of default and contains certain negative covenants that limit the ability of the Company and its subsidiaries to grant liens on assets, or to enter into sale-leaseback transactions. In addition, subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of the Senior Notes - 2017 below investment grade rating by both Moody’s Investors Services, Inc. and Standard & Poor’s Ratings Services within a specified time period, the Company will be required to make an offer to repurchase the Senior Notes - 2017 at a price equal to 101% of the principal amount of the Senior Notes - 2017, plus accrued and unpaid interest to the date of repurchase.

Senior Notes - 2007

During the third quarter of 2017, the Company made a payment of $250 million on the Senior Notes - 2007.

Commercial Paper

Commercial paper issued by the Company generally has terms of 90 days or less. As of ~~June~~September 30, 2017, there was no$40.0 million of commercial paper ~~outstanding.~~outstanding, which had a weighted average effective interest rate of 1.19%. As of September 30, 2017, commercial paper maturities did not extend for more than 30 days. The revolving credit facility is used as a backstop for the Company's commercial paper program. No commercial paper was issued during the ~~six~~nine months ended ~~June~~September 30, 2016.

Note 7. Income Taxes:

Uncertain Tax Positions

At ~~June~~September 30, 2017, the Company had $~~17.6~~18.9 million of unrecognized tax benefits recorded in Other liabilities and ~~$5.9~~$6.9 million in Other current liabilities. If these unrecognized tax benefits were recognized, the effective tax rate would be affected.

At ~~June~~September 30, 2017, the Company had accrued interest and penalties of $1.7 million classified in Other liabilities and ~~$0.5~~$0.7 million in Other current liabilities.

As of ~~June~~September 30, 2017, the Company’s aggregate provisions for uncertain tax positions, including interest and penalties, was ~~$25.7~~$28.2 million associated with various tax positions asserted in ~~foreign~~various jurisdictions, none of which is individually material.

The Company regularly repatriates a portion of current year earnings from select non–U.S. subsidiaries. No provision is made for additional taxes on undistributed earnings of subsidiary companies that are intended and planned to be indefinitely invested in such subsidiaries. We intend to, and have plans to, reinvest these earnings indefinitely in our foreign subsidiaries to fund local operations and/or capital projects.

The Company has ongoing income tax audits and legal proceedings which are at various stages of administrative or judicial review. In addition, the Company has open tax years with various taxing jurisdictions that range primarily from 2007 to 2016. Based on currently available information, we do not believe the ultimate outcome of any of these tax audits and other tax positions related to open tax years, when finalized, will have a material impact on our financial position.

The Company also has other ongoing tax audits and legal proceedings that relate to indirect taxes, such as value-added taxes, sales and use taxes and property taxes, which are discussed in Note 13.

Effective Tax Rate

The effective tax rate for the three months ended ~~June~~September 30, 2017 was ~~22.7%~~22.0% compared with ~~23.2%~~20.8% for the three months ended ~~June~~September 30, 2016. The quarter-over-quarter ~~decrease~~increase was largely due to higher repatriation costs partially offset by the impact of the global supply chain hub and mix of earnings as compared to the prior year. The effective tax rate for the nine months ended September 30, 2017 was 20.4% compared with 22.7% for the nine months ended September 30, 2016. The period-over-period decrease was primarily due to certain non-taxable gains on foreign currency and the impact of adopting the new accounting guidance on the tax effect of stock compensation vesting, a more favorable mix of earnings and the impact of the global supply chain hub, offset by unfavorable repatriation costs as compared to the prior year. The effective tax rate for the six months ended June 30, 2017 was 19.6% compared with 23.3% for the six months ended June 30, 2016. The year-over-year decrease was primarily due to various items (including certain non-taxable gains on foreign currency and the impact of adopting the new accounting guidance on the tax effect of stock compensation vesting), a more favorable mix of earnings and the impact of the global supply chain hub, offset by unfavorable repatriation costs as compared to the prior year.

Note 8. Stock Compensation ~~Plans:~~Plans

The Company has various plans under which its officers, senior management, other key employees and directors may be granted equity-based awards. Equity awards outstanding under the plans include PRSUs, restricted stock units ~~("RSUs")~~(RSUs), stock options, SSARs and Long-Term Incentive Plan awards; liability-based awards outstanding under the plans are cash-settled RSUs.

Stock-based compensation expense and related tax benefits were as follows:


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016			2017			2016			2017			2016
Equity-based awards	$	7,074		$	7,844		$	12,893		$	13,774		$	7,256		$	5,697		$	20,149		$	19,471
Liability-based awards	1,298			1,739			3,051			2,332			1,396			1,836			4,447			4,168
Total stock-based compensation expense	8,372			9,583			15,944			16,106			8,652			7,533			24,596			23,639
Less: tax benefit	(2,336		)	(2,816		)	(4,549		)	(4,789		)	(2,574		)	(2,174		)	(7,123		)	(6,963		)
Total stock-based compensation expense, after tax	$	6,036		$	6,767		$	11,395		$	11,317		$	6,078		$	5,359		$	17,473		$	16,676

Note 9. Segment Information:

The Company is organized into two operating segments: Flavors and Fragrances. These segments align with the internal structure of the Company used to manage these businesses. Performance of these operating segments is evaluated based on segment profit which is defined as operating profit before Restructuring and other charges, net, Global expenses (as discussed below) and certain non-recurring items, Interest expense, Other income (expense), net and Taxes on income.

The Global expenses caption below represent corporate and headquarters-related expenses which include legal, finance, human resources, certain incentive compensation expenses and other R&D and administrative expenses that are not allocated to individual operating segments.

Reportable segment information is as follows:


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016			2017			2016			2017			2016
Net sales:
Flavors	$	414,323		$	379,504		$	820,487		$	752,012		$	409,800		$	366,857		$	1,230,286		$	1,118,869
Fragrances	428,538			413,974			850,667			824,777			463,140			410,144			1,313,808			1,234,921
Consolidated	$	842,861		$	793,478		$	1,671,154		$	1,576,789		$	872,940		$	777,001		$	2,544,094		$	2,353,790
Segment profit:
Flavors	$	100,338		$	90,337		$	198,346		$	182,151		$	91,378		$	77,512		$	289,723		$	259,662
Fragrances	84,860			87,596			166,557			176,833			93,528			85,010			260,085			261,843
Global expenses	(13,398		)	(12,268		)	(29,594		)	(26,141		)	(17,598		)	(11,405		)	(47,193		)	(37,544		)
Restructuring and other charges, net ⁽¹⁾	(791		)	(182		)	(10,934		)	(283		)	(3,249		)	(190		)	(14,183		)	(473		)
Acquisition-related costs ⁽²⁾	(6,278		)	(213		)	(15,066		)	(1,249		)	(5,436		)	(786		)	(20,502		)	(2,035		)
Operational improvement initiative costs ⁽³⁾	(445		)	(831		)	(1,066		)	(1,099		)	(407		)	(802		)	(1,473		)	(1,901		)
Legal (charges) credits ⁽⁴⁾	(1,000		)	36			(1,000		)	1,482			—			(25,000		)	(1,000		)	(23,518		)
Gain on sales of assets ⁽⁵⁾	68			197			89			2,910			31			87			120			2,998
Tax assessment ⁽⁶⁾	19			—			(5,331		)	—			—			—			(5,331		)	—
Integration-related costs ⁽⁷⁾	(731		)	—			(1,923		)	—			(580		)	—			(2,501		)	—
FDA mandated product recall ⁽⁸⁾	(3,500		)	—			(3,500		)	—			—			—			(3,500		)	—
Operating profit	159,142			164,672			296,578			334,604			157,667			124,426			454,245			459,032
Interest expense	(17,556		)	(15,060		)	(30,363		)	(27,539		)	(19,221		)	(13,111		)	(49,584		)	(40,649		)
Other income (expense)	454			2,438			14,312			(118		)	2,880			2,075			17,192			1,954
Income before taxes	$	142,040		$	152,050		$	280,527		$	306,947		$	141,326		$	113,390		$	421,853		$	420,337


(1)	In 2017, charges represent severance costs related to the 2017 Productivity Program. In 2016, charges relate to accelerated depreciation which were recorded in Cost of goods sold.


(2)	Represents transaction costs related to the acquisitions of Fragrance Resources and PowderPure as well as the amortization of inventory "step-up" related to David Michael, Fragrance Resources and PowderPure in the 2017 period, and expense related to the amortization of inventory "step-up" and additional transaction costs related to the acquisition of Lucas Meyer in the 2016 period.


(3)	Represents accelerated depreciation in Hangzhou, China in both the 2017 and 2016 periods.


(4)	Represents additional charges related to litigation settlement in the 2017 period and ~~income receivable from~~reserve for litigation settlement in the ~~Spanish government related to the Spanish capital tax case in 2016.~~2016 period.


(5)	Represents gains on sale of assets in Latin America in the 2017 period and in Europe in the 2016 period.


(6)	Represents the reserve for a tax assessment related to commercial rent for prior periods.


(7)	Represents costs related to the integration of the David Michael and Fragrance Resources ~~acquisitions in the 2017 period.~~acquisitions.

(8)

Represents an estimate of the Company's incremental direct costs and customer reimbursement obligations, in excess of the Company's sales value of the recalled products, arising from an FDA mandated recall of consumer products as a result of raw material received and identified by the Company as containing contamination. (As discussed in Note 13, the sales value of the recalled products was reserved in the first quarter of 2017). While the Company does not believe that any of the affected raw material was included in its finished products delivered to the customer, as the delivered product included raw material of the same vendor lot that tested positive, the FDA, after being notified by the Company, initiated a recall of all consumer products including raw material from the affected vendor lot due to the potential for product contamination.

Net sales are attributed to individual regions based upon the destination of product delivery. Net sales related to the U.S. for the three months ended ~~June~~September 30, 2017 and 2016 were $~~244~~251 million and ~~$185~~$190 million, respectively and for the ~~six~~nine months ended ~~June~~September 30, 2017 and 2016 were ~~$449~~$731 million and ~~$365~~$555 million, respectively. Net sales attributed to all foreign countries in total for the three months ended ~~June~~September 30, 2017 and 2016 were ~~$599~~$622 million and ~~$608~~$587 million, respectively and for the ~~six~~nine months ended ~~June~~September 30, 2017 and 2016 were ~~$1,222~~$1,813 million and ~~$1,212~~$1,799 million, respectively. No country other than the U.S. had net sales in any period presented greater than 10% of total consolidated net sales.

Note 10. Employee Benefits:

Pension and other defined contribution retirement plan expenses included the following components:


U.S. Plans	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016			2017			2016			2017			2016
Service cost for benefits earned	$	698		$	772		$	1,395		$	1,543		$	698		$	771		$	2,093		$	2,314
Interest cost on projected benefit obligation	4,561			6,006			9,122			12,013			4,561			6,007			13,683			18,020
Expected return on plan assets	(9,246		)	(8,070		)	(18,492		)	(16,139		)	(9,246		)	(8,069		)	(27,737		)	(24,208		)
Net amortization and deferrals	1,793			1,385			3,585			2,772			1,793			1,387			5,377			4,159
Net periodic benefit cost	(2,194		)	93			(4,390		)	189
Net periodic benefit (income) cost													(2,194		)	96			(6,584		)	285
Defined contribution and other retirement plans	2,524			2,211			4,779			4,612			1,939			1,211			6,718			5,823
Total expense	$	330		$	2,304		$	389		$	4,801
Total (income) expense													$	(255	)	$	1,307		$	134		$	6,108

Non-U.S. Plans	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016			2017			2016			2017			2016
Service cost for benefits earned	$	5,610		$	3,863		$	11,220		$	7,638		$	5,956		$	3,863		$	17,867		$	11,443
Interest cost on projected benefit obligation	3,911			6,372			7,822			12,737			4,066			6,372			12,198			18,890
Expected return on plan assets	(12,334		)	(11,985		)	(24,668		)	(23,934		)	(12,873		)	(11,985		)	(38,618		)	(35,526		)
Net amortization and deferrals	3,988			3,286			7,977			6,550			4,185			3,286			12,554			9,738
Net periodic benefit cost	1,175			1,536			2,351			2,991			1,334			1,536			4,001			4,545
Defined contribution and other retirement plans	1,616			1,763			2,913			3,470			1,470			1,705			4,383			5,175
Total expense	$	2,791		$	3,299		$	5,264		$	6,461		$	2,804		$	3,241		$	8,384		$	9,720

The Company expects to contribute a total of approximately $2$3 - $10 million to its U.S. pension plans during 2017. During the ~~six~~nine months ended ~~June~~September 30, 2017, no contributions were made to the qualified U.S. pension plans, ~~$29.3~~$33.6 million of contributions were made to the non-U.S. pension plans and ~~$2.2~~$3.3 million of benefit payments were made with respect to the Company's non-qualified U.S. pension plan.

As of January 1, 2017, the Company changed its approach for calculating the discount rate which is applied to the Consolidated Balance Sheet and Consolidated Statement of Comprehensive Income from a single weighted-average discount rate approach to a multiple discount rate approach. The impact of this change for the full year 2017 is estimated to be a reduction of approximately $8 million in pension expense.

Expense recognized for postretirement benefits other than pensions included the following components:


	Three Months Ended June 30,						Six Months Ended June 30,						Three Months Ended September 30,						Nine Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016			2017			2016			2017			2016
Service cost for benefits earned	$	221		$	214		$	442		$	429		$	221		$	214		$	663		$	644
Interest cost on projected benefit obligation	588			787			1,176			1,574			588			787			1,764			2,360
Net amortization and deferrals	(1,046		)	(1,355		)	(2,092		)	(2,710		)	(1,046		)	(1,355		)	(3,138		)	(4,065		)
Total postretirement benefit income	$	(237	)	$	(354	)	$	(474	)	$	(707	)	$	(237	)	$	(354	)	$	(711	)	$	(1,061	)

The Company expects to contribute approximately $5 million to its postretirement benefits other than pension plans during 2017. In the ~~six~~nine months ended ~~June~~September 30, 2017, ~~$2.2~~$3.1 million of contributions were made.

Note 11. Financial Instruments:

Fair Value

Accounting guidance on fair value measurements specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These two types of inputs create the following fair value hierarchy:

Level 1–Quoted prices for identical instruments in active markets.

Level 2–Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.

Level 3–Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. We determine the fair value of structured liabilities (where performance is linked to structured interest rates, inflation or currency risks) using the LIBOR swap curve and forward interest and exchange rates at period end. Such instruments are classified as Level 2 based on the observability of significant inputs to the model. We do not have any instruments classified as Level 1 or Level 3, other than those included in pension asset trusts as discussed in Note 1314 of our 2016 Form 10-K.

These valuations take into consideration our credit risk and our counterparties’ credit risk. The estimated change in the fair value of these instruments due to such changes in our own credit risk (or instrument-specific credit risk) was immaterial as of ~~June~~September 30, 2017.

The amounts recorded in the balance sheet (carrying amount) and the estimated fair values of financial instruments at ~~June~~September 30, 2017 and December 31, 2016 consisted of the following:


	June 30, 2017				December 31, 2016				September 30, 2017				December 31, 2016
(DOLLARS IN THOUSANDS)	Carrying Amount		Fair Value		Carrying Amount		Fair Value		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Cash and cash equivalents ⁽¹⁾	$	491,386	$	491,386	$	323,992	$	323,992	$	316,002	$	316,002	$	323,992	$	323,992
Credit facilities and bank overdrafts ⁽²⁾	38,720		38,720		13,599		13,599		9,807		9,807		13,599		13,599
Commercial paper ⁽²⁾									39,957		39,957		—		—
Long-term debt: ⁽³⁾
Senior notes - 2007	499,735		551,713		499,676		556,222		249,765		297,010		499,676		556,222
Senior notes - 2013	298,519		306,361		297,986		302,376		298,594		307,675		297,986		302,376
Euro Senior notes - 2016	563,981		611,397		512,764		546,006		582,514		614,498		512,764		546,006
Senior notes - 2017	492,877		511,789		—		—		492,653		497,998		—		—


(1)	The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments.


(2)	The carrying amount of our credit facilities, bank overdrafts and commercial paper approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments.


(3)	The fair value of our long-term debt was calculated using discounted cash flows applying current interest rates and current credit spreads based on our own credit risk.

Derivatives

The Company periodically enters into foreign currency forward contracts with the objective of reducing exposure to cash flow volatility associated with our intercompany loans, foreign currency receivables and payables, and anticipated purchases of certain raw materials used in operations. These contracts generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months and are with counterparties which are major international financial institutions.

During the ~~six~~nine months ended ~~June~~September 30, 2017 and the year ended December 31, 2016, the Company entered into several forward currency contracts which qualified as net investment hedges, in order to mitigate a portion of our net European investments from foreign currency risk. The effective portions of net investment hedges are recorded in Other comprehensive income (“OCI”) as a component of Foreign currency translation adjustments in the accompanying Consolidated Statement of Comprehensive Income. Realized gains (losses) are deferred in accumulated other comprehensive income ("AOCI") where they will remain until the net investments in our European subsidiaries are divested. The outstanding forward currency contracts have remaining maturities of approximately one year. ~~Ten~~Fourteen of these forward currency contracts matured during the ~~six~~nine months ended ~~June~~September 30, 2017.

Subsequent to the issuance of the Euro Senior Notes - 2016 during the first quarter of 2016, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable

to foreign exchange movements is recorded in OCI as a component of Foreign currency translation adjustments in the accompanying Consolidated Statement of Comprehensive Income.

During the ~~six~~nine months ended ~~June~~September 30, 2017 and the year ended December 31, 2016, the Company entered into several forward currency contracts which qualified as cash flow hedges. The objective of these hedges is to protect against the currency risk associated with forecasted U.S. dollar (USD) denominated raw material purchases made by Euro (EUR) functional currency entities which result from changes in the EUR/USD exchange rate. The effective portions of cash flow hedges are recorded in OCI as a component of gains/(losses) on derivatives qualifying as hedges in the accompanying Consolidated Statement of Comprehensive Income. Realized gains/(losses) in AOCI related to cash flow hedges of raw material purchases are recognized as a component of Cost of goods sold in the accompanying Consolidated Statement of Comprehensive Income in the same period as the related costs are recognized.

The Company has entered into interest rate swap agreements that effectively converted the fixed rate on a portion of our long-term borrowings to a variable short-term rate based on the LIBOR plus an interest markup. These swaps are designated as fair value hedges. Amounts recognized in Interest expense were immaterial for the three and ~~six~~nine months ended ~~June~~September 30, 2017.

During the first quarter of 2016, the Company entered into and terminated two Euro interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt. These swaps were designated as cash flow hedges. The effective portions of

cash flow hedges are recorded in OCI as a component of Losses on derivatives qualifying as hedges in the accompanying Consolidated Statement of Comprehensive Income. The Company incurred a loss of Euro 2.9 million ($3.2 million) due to the termination of these swaps. The loss is being amortized as interest expense over the life of the Euro Senior Notes - ~~2016 as discussed in Note 6.~~2016.

During the fourth quarter of 2016 and the first quarter of 2017, the Company entered into interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt, which are designated as cash flow hedges. The various hedge instruments were settled upon issuance of the debt on May 18, 2017 and resulted in a loss of approximately $5.3 million. As discussed in Note 6, the loss is being amortized as interest expense over the life of the Senior Notes - 2017.

The effective portions of cash flow hedges are recorded in OCI as a component of Losses/gains on derivatives qualifying as hedges in the accompanying Consolidated Statement of Comprehensive Income.

The following table shows the notional amount of the Company’s derivative instruments outstanding as of ~~June~~September 30, 2017 and December 31, 2016:

(DOLLARS IN THOUSANDS) June 30, 2017 December 31, 2016
Foreign currency contracts $ 687,437
$ 527,500
Interest rate swaps 350,000
412,500



(DOLLARS IN THOUSANDS)	September 30, 2017		December 31, 2016
Foreign currency contracts	$	756,631	$	527,500
Interest rate swaps	150,000		412,500

The following tables show the Company’s derivative instruments measured at fair value (Level 2 of the fair value hierarchy), as reflected in the Consolidated Balance Sheets as of ~~June~~September 30, 2017 and December 31, 2016:


	June 30, 2017						September 30, 2017
(DOLLARS IN THOUSANDS)	Fair Value of Derivatives Designated as Hedging Instruments		Fair Value of Derivatives Not Designated as Hedging Instruments		Total Fair Value		Fair Value of Derivatives Designated as Hedging Instruments		Fair Value of Derivatives Not Designated as Hedging Instruments		Total Fair Value
Derivative assets ^(a)
Foreign currency contracts	$	927	$	8,055	$	8,982	$	1,171	$	14,335	$	15,506
	$	927	$	8,055	$	8,982	$	1,171	$	14,335	$	15,506
Derivative liabilities ^(b)
Foreign currency contracts	$	7,020	$	8,852	$	15,872	$	9,942	$	2,016	$	11,958
Interest rate swaps	158		—		158		604		—		604
	$	7,178	$	8,852	$	16,030	$	10,546	$	2,016	$	12,562



	December 31, 2016
(DOLLARS IN THOUSANDS)	Fair Value of Derivatives Designated as Hedging Instruments		Fair Value of Derivatives Not Designated as Hedging Instruments		Total Fair Value
Derivative assets ^(a)
Foreign currency contracts	$	13,765	$	7,737	$	21,502
Interest rate swaps	335		—		335
	$	14,100	$	7,737	$	21,837
Derivative liabilities ^(b)
Foreign currency contracts	$	46	$	2,209	$	2,255
Interest rate swaps	725		—		725
	$	771	$	2,209	$	2,980


(a)	Derivative assets are recorded to Prepaid expenses and other current assets in the Consolidated Balance Sheet.


(b)	Derivative liabilities are recorded as Other current liabilities in the Consolidated Balance Sheet.

The following table shows the effect of the Company’s derivative instruments which were not designated as hedging instruments in the Consolidated Statement of Comprehensive Income for the three and ~~six~~nine months ended ~~June~~September 30, 2017 and 2016 (in thousands):


Derivatives Not Designated as Hedging Instruments	Amount of Gain (Loss) Recognized in Income on Derivative						Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative						Location of Gain (Loss) Recognized in Income on Derivative
	Three Months Ended June 30,							Three Months Ended September 30,
	2017			2016				2017			2016
Foreign currency contracts	$	(3,054	)	$	1,395		Other (income) expense, net	$	4,024		$	(3,313	)	Other (income) expense, net
Derivatives Not Designated as Hedging Instruments	Amount of Gain (Loss) Recognized in Income on Derivative						Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative						Location of Gain (Loss) Recognized in Income on Derivative
	Six Months Ended June 30,							Nine Months Ended September 30,
	2017			2016				2017			2016
Foreign currency contracts	$	(13,181	)	$	(3,548	)	Other (income) expense, net	$	(9,157	)	$	(6,860	)	Other (income) expense, net

Most of these net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods.

The following table shows the effect of the Company’s derivative instruments designated as cash flow and net investment hedging instruments, net of tax, in the Consolidated Statements of Comprehensive Income for the three and ~~six~~nine months ended ~~June~~September 30, 2017 and 2016 (in thousands):


	Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion)						Location of (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion)						Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion)						Location of (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion)
	Three Months Ended June 30,							Three Months Ended June 30,						Three Months Ended September 30,							Three Months Ended September 30,
	2017			2016				2017			2016			2017			2016				2017			2016
Derivatives in Cash Flow Hedging Relationships:
Foreign currency contracts	$	(6,328	)	$	612		Cost of goods sold	$	1,789		$	2,736		$	(4,229	)	$	98		Cost of goods sold	$	1,815		$	(544	)
Interest rate swaps ⁽¹⁾	(5,439		)	171			Interest expense	(186		)	(171		)	216			171			Interest expense	(216		)	(171		)
Derivatives in Net Investment Hedging Relationships:
Foreign currency contracts	(2,082		)	1,934			N/A	—			—			(1,130		)	(224		)	N/A	—			—
Euro Senior notes - 2016	(19,780		)	9,649			N/A	—			—			(11,861		)	(2,856		)	N/A	—			—
Total	$	(33,629	)	$	12,366			$	1,603		$	2,565		$	(17,004	)	$	(2,811	)		$	1,599		$	(715	)

	Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion)						Location of (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion)						Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion)						Location of (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion)
	Six Months Ended June 30,							Six Months Ended June 30,						Nine Months Ended September 30,							Nine Months Ended September 30,
	2017			2016				2017			2016			2017			2016				2017			2016
Derivatives in Cash Flow Hedging Relationships:
Foreign currency contracts	$	(9,276	)	$	(6,391	)	Cost of goods sold	$	2,247		$	5,352		$	(13,505	)	$	(6,293	)	Cost of goods sold	$	4,062		$	4,808
Interest rate swaps ⁽¹⁾	(4,243		)	(3,001		)	Interest expense	(357		)	(257		)	(4,027		)	(2,830		)	Interest expense	(573		)	(428		)

Derivatives in Net Investment Hedging Relationships:
Foreign currency contracts	(3,128		)	(470		)	N/A	—			—			(4,258		)	(694		)	N/A	—			—
Euro Senior notes - 2016	(31,189		)	9,649			N/A	—			—			(43,050		)	6,793			N/A	—			—
Total	$	(47,836	)	$	(213	)		$	1,890		$	5,095		$	(64,840	)	$	(3,024	)		$	3,489		$	4,380

(1) Interest rate swaps were entered into as pre-issuance hedges.

No ineffectiveness was experienced in the above noted cash flow or net investment hedges during the three and ~~six~~nine months ended ~~June~~September 30, 2017 and 2016.

The Company expects that approximately ~~$2.9~~$5.4 million (net of tax) of derivative ~~gains~~loss included in AOCI at ~~June~~September 30, 2017, based on current market rates, will be reclassified into earnings within the next 12 months. The majority of this amount will vary due to fluctuations in foreign currency exchange rates.

Note 12. Accumulated Other Comprehensive Income (Loss):

The following tables present changes in the accumulated balances for each component of other comprehensive income, including current period other comprehensive income and reclassifications out of accumulated other comprehensive income:


	Foreign Currency Translation Adjustments			(Losses) Gains on Derivatives Qualifying as Hedges			Pension and Postretirement Liability Adjustment			Total			Foreign Currency Translation Adjustments				(Losses) Gains on Derivatives Qualifying as Hedges			Pension and Postretirement Liability Adjustment			Total
(DOLLARS IN THOUSANDS)
Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2016	$	(352,025	)	$	7,604		$	(335,674	)	$	(680,095	)	$	(352,025	)		$	7,604		$	(335,674	)	$	(680,095	)
OCI before reclassifications	22,304			(11,629		)	—			10,675			42,023				(14,044		)	—			27,979
Amounts reclassified from AOCI	(12,214		)	(1,890		)	7,323			(6,781		)	(12,214		)	*	(3,489		)	11,168			(4,535		)
Net current period other comprehensive income (loss)	10,090			(13,519		)	7,323			3,894			29,809				(17,533		)	11,168			23,444
Accumulated other comprehensive (loss) income, net of tax, as of June 30, 2017	$	(341,935	)	$	(5,915	)	$	(328,351	)	$	(676,201	)
Accumulated other comprehensive (loss) income, net of tax, as of September 30, 2017													$	(322,216	)		$	(9,929	)	$	(324,506	)	$	(656,651	)

* Represents a foreign currency exchange gain from the release of a currency translation adjustment upon the liquidation of a foreign entity in 2017 as disclosed in Note 1.


	Foreign Currency Translation Adjustments			(Losses) Gains on Derivatives Qualifying as Hedges			Pension and Postretirement Liability Adjustment			Total			Foreign Currency Translation Adjustments			(Losses) Gains on Derivatives Qualifying as Hedges			Pension and Postretirement Liability Adjustment			Total
(DOLLARS IN THOUSANDS)
Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2015	$	(297,499	)	$	9,401		$	(325,342	)	$	(613,440	)	$	(297,499	)	$	9,401		$	(325,342	)	$	(613,440	)
OCI before reclassifications	9,389			(4,297		)	—			5,092			3,198			(4,744		)	—			(1,546		)
Amounts reclassified from AOCI	—			(5,095		)	5,133			38			—			(4,380		)	7,719			3,339
Net current period other comprehensive income (loss)	9,389			(9,392		)	5,133			5,130			3,198			(9,124		)	7,719			1,793
Accumulated other comprehensive (loss) income, net of tax, as of June 30, 2016	$	(288,110	)	$	9		$	(320,209	)	$	(608,310	)
Accumulated other comprehensive (loss) income, net of tax, as of September 30, 2016													$	(294,301	)	$	277		$	(317,623	)	$	(611,647	)

The following table provides details about reclassifications out of accumulated other comprehensive income to the Consolidated Statement of Comprehensive Income:


	Six Months Ended June 30, 2017			Six Months Ended June 30, 2016			Affected Line Item in the Consolidated Statement of Comprehensive Income	Nine Months Ended September 30, 2017			Nine Months Ended September 30, 2016			Affected Line Item in the Consolidated Statement of Comprehensive Income
(DOLLARS IN THOUSANDS)
(Losses) gains on derivatives qualifying as hedges
Foreign currency contracts	$	2,568		$	6,117		Cost of goods sold	$	4,642		$	5,495		Cost of goods sold
Interest rate swaps	(357		)	(257		)	Interest expense	(573		)	(428		)	Interest expense
	(321		)	(765		)	Provision for income taxes	(580		)	(687		)	Provision for income taxes
	$	1,890		$	5,095		Total, net of income taxes	$	3,489		$	4,380		Total, net of income taxes
(Losses) gains on pension and postretirement liability adjustments
Prior service cost	$	(3,512	)	$	3,735		^(a)	$	5,304		$	5,602		^(a)
Actuarial losses	(12,982		)	(10,347		)	^(a)	(20,097		)	(15,434		)	^(a)
	9,171			1,479			Provision for income taxes	3,625			2,113			Provision for income taxes
	$	(7,323	)	$	(5,133	)	Total, net of income taxes	$	(11,168	)	$	(7,719	)	Total, net of income taxes


(a)	The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. Refer to Note 14 of our 2016 Form 10-K for additional information regarding net periodic benefit cost.

Note 13. Commitments and Contingencies:

Guarantees and Letters of Credit

The Company has various bank guarantees and letters of credit which are available for use to support its ongoing business operations and to satisfy governmental requirements associated with pending litigation in various jurisdictions.

At ~~June~~September 30, 2017, we had total bank guarantees and standby letters of credit of approximately $~~37.1~~38.1 million with various financial institutions. Included in the above aggregate amount is a total of ~~$15.9~~$16.3 million in bank guarantees which the Company has posted for certain assessments in Brazil for other diverse income tax and indirect tax disputes related to fiscal years 1998-2011. There were no material amounts utilized under the standby letters of credit as of ~~June~~September 30, 2017.

In order to challenge the assessments in these cases in Brazil, the Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in the amount of approximately ~~$15.2~~$15.6 million as of ~~June~~September 30, 2017.

Lines of Credit

The Company has various lines of credit which are available to support its ongoing business operations. At ~~June~~September 30, 2017, we had available lines of credit (in addition to the ~~$921.6~~$950 million of capacity under the Credit Facility discussed in Note 9 of our 2016 Form 10-K) of approximately $~~75.0~~75.6 million with various financial institutions. There were no significant amounts drawn down pursuant to these lines of credit as of ~~June~~September 30, 2017.

Litigation

The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss. A loss contingency is accrued in the Company’s consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly sensitive and requires judgments about future events. On at least a quarterly basis, the Company reviews contingencies related to litigation to determine the adequacy of accruals. The amount of ultimate loss may differ from these estimates and further events may require the Company to increase or decrease the amounts it has accrued on any matter.

Periodically, we assess our insurance coverage for all known claims, where applicable, taking into account aggregate coverage by occurrence, limits of coverage, self-insured retentions and deductibles, historical claims experience and claims experience with our insurance carriers. The liabilities are recorded at management’s best estimate of the probable outcome of the lawsuits and claims, taking into consideration the facts and circumstances of the individual matters as well as past experience on similar matters. At each balance sheet date, the key issues that management assesses are whether it is probable

that a loss as to asserted or unasserted claims has been incurred and if so, whether the amount of loss can be reasonably estimated. We record the expected liability with respect to claims in Other liabilities and expected recoveries from our insurance carriers in Other assets. We recognize a receivable when we believe that realization of the insurance receivable is probable under the terms of the insurance policies and our payment experience to date.

Environmental

Over the past 20 years, various federal and state authorities and private parties have claimed that we are a Potentially Responsible Party (“PRP”) as a generator of waste materials for alleged pollution at a number of waste sites operated by third parties located principally in New Jersey and have sought to recover costs incurred and to be incurred to clean up the sites.

We have been identified as a PRP at eight facilities operated by third parties at which investigation and/or remediation activities may be ongoing. We analyze our potential liability on at least a quarterly basis. We accrue for environmental liabilities when they are probable and estimable. We estimate our share of the total future cost for these sites to be less than $5 million.

While joint and several liability is authorized under federal and state environmental laws, we believe the amounts we have paid and anticipate paying in the future for clean-up costs and damages at all sites are not material and will not have a material adverse effect on our financial condition, results of operations or liquidity. This assessment is based upon, among other things, the involvement of other PRPs at most of the sites, the status of the proceedings, including various settlement agreements and consent decrees, and the extended time period over which payments will likely be made. There can be no assurance, however, that future events will not require us to materially increase the amounts we anticipate paying for clean-up costs and damages at these sites, and that such increased amounts will not have a material adverse effect on our financial condition, results of operations or cash flows.

China Facilities

Guangzhou Flavors plant

During 2015, the Company was notified by Chinese authorities of compliance issues pertaining to the emission of odors from several of its plants in China. As a result, the Company's Guangzhou Flavors plant in China was temporarily ~~idled.~~idled in 2015. The Company has made additional capital improvements in odor-abatement equipment at these plants to address these issues and is in the process of building a second Flavors plant in China, which is expected to begin operating in the first quarter of 2019.

During the fourth quarter of 2016, the Company was notified that certain governmental authorities have begun to evaluate a change in the zoning of the Guangzhou Flavors plant. The zoning, if changed, would prevent the Company from continuing to manufacture product at the existing plant. The ultimate outcome of any change that the governmental authorities may propose, the timing of such a change and the nature of any compensation arrangements that might be provided to the Company are uncertain.

The net book value of the existing plant was approximately ~~$67~~$68 million as of ~~June~~September 30, 2017.

Zhejiang Ingredients plant

~~The~~In the first quarter of 2016, the Company ~~has~~ received a request from the Chinese government to relocate its Fragrance Ingredients plant in Zhejiang, China. ~~The~~Since then, the Company ishas been in discussions with the government regarding the timing of the requested relocation and the amount and nature of government compensation to be provided to the Company. The Company expects to conclude discussions with the ~~Government~~government in the fourth quarter of 2017. The net book value of the current plant was approximately $25 million as of ~~June~~September 30, 2017. ~~Depending upon~~Based on the ~~ultimate outcome of~~current expectations regarding the ~~discussions with~~compensation package, the ~~Chinese government,~~Company estimates that between ~~$0-25~~$0-12 million of the remaining net book value may be subject to accelerated ~~depreciation.~~depreciation beginning in the fourth quarter of 2017. The Company expects to relocate approximately half of the facility by the end of 2018 and the remainder of the facility by the end of 2019.

Total China Operations

The total carrying value of our six existing plants in China (two of which are currently under construction) was approximately ~~$139~~$145 million as of ~~June~~September 30, 2017.

If the Company is required to close a plant, or operate one at significantly reduced production levels on a permanent basis, the Company may be required to record charges that could have a material impact on its consolidated financial results of operations, financial position and cash flows in future periods.

Other Contingencies

The Company has contingencies involving third parties (such as labor, contract, technology or product-related claims or litigation) as well as government-related items in various jurisdictions in which we operate pertaining to such items as ~~value-added~~value-

added taxes, other indirect taxes, customs and duties and sales and use taxes. It is possible that cash flows or results of operations, in any period, could be materially affected by the unfavorable resolution of one or more of these contingencies.

The most significant government-related contingencies exist in Brazil. With regard to the Brazilian matters, we believe we have valid defenses for the underlying positions under dispute; however, in order to pursue these defenses, we are required to, and have provided, bank guarantees and pledged assets in the aggregate amount of ~~$31.1~~$31.9 million. The Brazilian matters take an extended period of time to proceed through the judicial process and there are a limited number of rulings to date.

As previously disclosed, in March 2012, ZoomEssence, Inc. filed a complaint against the Company in the U.S. District Court for the District of New Jersey alleging trade secret misappropriation, breach of contract and unjust enrichment in connection with certain spray dry technology disclosed to the Company. ZoomEssence sought an injunction and monetary damages. In November 2014, the Company filed a counterclaim against ZoomEssence alleging trade secret misappropriation, breach of contract, breach of the implied covenant of good faith and fair dealing, unjust enrichment, misappropriation of confidential and proprietary information, common law unfair competition, tortious interference with contractual relations, and conversion. During the second quarter of 2017, the Company and ZoomEssence mutually agreed to settle all claims and counterclaims. The parties agreed to dismiss their claims against one another, with prejudice and without any admission of liability or wrongful conduct, to avoid any further expense and disruption from the litigation. The complaint was dismissed, with prejudice, on July 5, 2017. Under the settlement agreement, the Company made a one-time payment to ZoomEssence of $56 million during the second quarter of 2017 and the parties exchanged full mutual releases. Accordingly, the Company recorded an additional charge of $1 million during the second quarter of 2017.

The Company periodically incurs product liability claims based on product that is sold to customers that may be defective or otherwise not in accordance with the customer’s requirements. As previously disclosed, in the first quarter of 2017, the Company was made aware of a claim for product that was subject to a product recall. As of ~~June~~September 30, 2017, the Company had recorded a total charge of approximately $5.3 million with respect to this claim. In addition to the charge of $1.8 million recorded in the first quarter of 2017, an additional $3.5 million was recorded during the second quarter of 2017. The second

quarter charge reflects additional information on specific volumes of affected products, which information became available in the second quarter of 2017. This amount principally represents an accrual for the claim based on management's best estimate of volumes of customer products subject to the recall. Additionally, appropriate reserves have been established for all remaining inventory at the Company's manufacturing site. While it is probable that the Company will incur additional losses related to this claim, the amount of the ultimate claim that will be paid is not currently estimable as the following information is not yet available: details as to the amount of product that will ultimately be returned and the customer’s direct manufacturing and other production costs; costs related to the customer’s recall efforts; costs to dispose of defective product; and other claims that the customer may make. While it is not currently possible to estimate the amount of losses, such losses when recorded will affect income from operations in future individual quarters. The Company does not believe that the ultimate settlement of the claim will have a material impact on its financial condition. Separately, the Company expects to pursue reimbursement of all or a portion of costs, once incurred, from its insurance company and/or the supplier; however, the nature, timing and amount of any such reimbursement cannot be determined at this time.

The Company determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that either a loss is reasonably possible or a loss in excess of accrued amounts is reasonably possible and the amount of losses or range of losses is determinable. For all third party contingencies (including labor, contract, technology, tax, product-related claims and business litigation), the Company currently estimates that the aggregate range of reasonably possible estimable losses in excess of any accrued liabilities is $0 to approximately $8$23 million. The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

We are also a party to other litigation arising in the ordinary course of our business. We do not expect the outcome of these cases, singly or in the aggregate, to have a material effect on our consolidated financial condition.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Company background

We are a leading innovator of sensorial experiences, co-creating unique products that consumers taste, smell, or feel in fine fragrances and cosmetics, detergents and household goods, and food and beverages. We take advantage of our capabilities in consumer insights, research and product development (“R&D”), creative expertise and customer intimacy to partner with our customers in developing innovative and differentiated offerings for consumers. We believe that this collaborative approach will generate market share gains for our customers. We operate in two business segments, Flavors and Fragrances.

Flavors are the key building blocks that impart taste experiences in food and beverage products and, as such, play a significant role in determining consumer preference for the end products in which they are used. As a leading creator of flavors, we help our customers deliver on the promise of delicious and healthy foods and drinks that appeal to consumers. While we are a global leader, our flavors business is more regional in nature, with different formulas that reflect local taste preferences. Our flavors compounds are ultimately used by our customers in four end-use categories: (1) Savory, (2) Beverages, (3) Sweet and (4) Dairy.

We are a global leader in the creation of fragrance compounds that are integral elements in the world’s finest perfumes and best-known consumer products, within fabric care, home care, personal wash, hair care and toiletries products. Our Fragrances business consists of Fragrance Compounds and Fragrance Ingredients. Our Fragrance Compounds are organized into two broad categories, (1) Fine Fragrances and (2) Consumer Fragrances. Consumer Fragrances consists of five end-use categories of products: (1) Fabric Care, (2) Home Care, (3) Personal Wash, (4) Hair Care and (5) Toiletries. Also included in the Fragrances business unit are Fragrance Ingredients, consisting of cosmetic active and functional ingredients. Fragrance Ingredients are used internally and sold to third parties, including customers and competitors, for use in preparation of compounds.

The flavors and fragrances market is part of a larger market which supplies a wide variety of ingredients and compounds used in consumer products. The broader market includes large multi-national companies and smaller regional and local participants that supply products such as seasonings, texturizers, spices, enzymes, certain food-related commodities, fortified products and cosmetic ingredients. The global market for flavors and fragrances has expanded consistently, primarily as a result of an increase in demand for, as well as an increase in the variety of, consumer products containing flavors and fragrances. In 2016, the flavors, fragrances and cosmetic actives and functional ingredients market, in which we compete, was estimated by management to be approximately $20.0 billion and is forecasted to grow approximately 2-3% by 2020, primarily driven by expected growth in emerging markets; however the exact size of the global market is not available due to fragmentation of data. We, together with the other top three companies, are estimated to represent approximately two-thirds of the total estimated sales in the global flavors and fragrances sub-segment of the broader market.

Development of new flavors and fragrance compounds is driven by a variety of sources, including requests from our customers, who are in need of a specific flavor or fragrance for use in a new or modified consumer product, or as a result of internal initiatives stemming from our consumer insights program. Our product development team works in partnership with our scientists and researchers to optimize the consumer appeal of the flavor or fragrance. It then becomes a collaborative process between our researchers, our product development team and our customers to perfect the flavor or fragrance so that it is ready to be included in the final consumer product.

On April 7, 2017, we completed the acquisition of Columbia PhytoTechnology, LLC d/b/a PowderPure ("PowderPure"), a processor of all-natural food ingredients, for approximately $55.0 million. The purchase price was funded from existing resources including drawdown on our credit facility and proceeds from commercial paper. This acquisition was accounted for as a business combination and is not expected to have a material impact on the Consolidated Statement of Comprehensive Income for 2017.

On January 17, 2017, we completed the acquisition of Fragrance Resources, a creator of specialty fine fragrances, for approximately Euro 142.0 million (approximately $150.5 million). The purchase price was funded from existing resources including drawdown on our credit facility and proceeds from commercial paper. The acquisition strengthened our fragrances market position in North America and Germany. This acquisition was accounted for as a business combination and is not expected to have a material impact on the Consolidated Statement of Comprehensive Income for 2017.

2017 Overview

Net sales during the ~~second~~third quarter of 2017 increased 6%12% on both a reported basis and 8% on a currency neutral basis (which excludes the effects of changes in currency) versus the 2016 period, with the effect of acquisitions contributing approximately 6% to both reported and currency neutral growth rates. Sales growth, excluding acquisitions, reflects new win performance (net of losses) ~~partially offset by~~in both Flavors and Fragrances, volume growth in Fragrances and lower volume declines on existing business in ~~both Flavors and Fragrances.~~Flavors.

Exchange rate fluctuations had ~~a 200 basis point (bps) unfavorable~~no impact on net sales for the ~~second quarter, due to the strengthening of the U.S. dollar.~~third quarter. The effect of exchange rates can vary by business and region, depending upon the mix of sales by destination country as well as the relative percentage of local sales priced in U.S. dollars versus local currencies.

Gross margins decreased ~~year-over-year~~ to ~~44.4%~~43.8% in the ~~second~~third quarter of 2017 from ~~46.1%~~44.6% in the 2016 period, driven primarily by unfavorable price versus input costs and weaker sales mix which were only partially offset by cost savings and productivity initiatives and the impact of acquisitions. Included in the ~~second~~third quarter of 2017 were ~~$9.6~~$5.7 million of acquisition-related amortization of inventory "step-up" costs, ~~costs associated with product recalls,~~ operational improvement initiative and integration-related costs compared to $1.0 million of operational improvement initiative and restructuring costs included in the ~~second~~third quarter of 2016. Excluding these items, gross margin decreased 6030 bps compared to the prior year period. The overall raw material cost base continues to be relatively stable, but upward trending. We believe that we will continue to see higher prices in 2017 on certain categories (such as vanilla and citrus) and to a lesser extent oil-based derivatives. We continue to seek improvements in our margins through operational performance, cost reduction efforts and mix enhancement.

FINANCIAL PERFORMANCE OVERVIEW

Sales

Reported sales in the ~~second~~third quarter of 2017 increased approximately ~~6%.~~12% as compared to the 2016 period. We continued to benefit from our diverse portfolio of end-use product categories and geographies and had currency neutral growth in ~~three of our~~all four regions and all four of our Flavors end-use product categories. Sales growth excluding acquisitions was driven by new win performance ~~partially offset by~~in both Flavors and Fragrances, volume growth in Fragrances and lower volume declines on existing business in ~~both~~Flavors. Flavors ~~and Fragrances. Flavors~~ achieved ~~reported~~ sales growth of 9%12% on a reported and currency neutral ~~growth of~~ ~~11%~~,basis, with the effect of acquisitions contributing approximately 7% to both reported and currency neutral growth rates. Fragrances achieved reported sales growth of 4%13% and currency neutral sales growth of 5%12%, with the effect of acquisitions contributing approximately 4%5% to both reported and currency neutral growth rates. Additionally, Fragrance Ingredients sales were up 7%9% on a reported basis and 9%8% on a currency neutral basis. Overall, our ~~second~~third quarter 2017 results reflected ~~flat sales~~7% growth from emerging markets and 3%5% growth from developed markets which each represented 50% of total sales. From a geographic perspective, for the ~~second~~third quarter of 2017, North America (NOAM), Europe, Africa and the Middle East (EAME) ~~and~~, Latin America (LA) and Greater Asia (GA) all delivered sales growth, led by NOAM with ~~19%~~18%. ~~Greater Asia (GA) sales declined 3%.~~

Operating profit

Operating profit ~~decreased $5.5~~increased $33.2 million to ~~$159.1~~$157.7 million ~~(18.9%~~(18.1% of sales) in the 2017 ~~second~~third quarter compared to ~~$164.7~~$124.4 million ~~(20.8%~~(16.0% of sales) in the comparable 2016 period. The ~~second~~third quarter of 2017 included ~~$12.7~~$9.6 million of acquisition-related costs, ~~costs associated with product recalls, legal charges,~~ restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets compared to ~~$1.0~~$26.7 million of legal charges, acquisition-related, restructuring and operational improvement initiative costs which were partially offset by gains on sales of fixed assets ~~and a favorable legal settlement~~ in the ~~prior year~~2016 period. Excluding these charges, adjusted operating profit was ~~$171.8~~$167.3 million ~~(20.4%~~(19.2% of sales) for the ~~second~~third quarter of 2017, an increase from ~~$165.7~~$151.1 million ~~(20.9%~~(19.4% of sales) for the ~~second~~third quarter of ~~2016.~~2016, principally driven by volume growth, acquisitions and productivity initiatives which more than offset weaker sales mix, incentive compensation and price to input costs. Foreign currency changes had a ~~2.5% unfavorable~~4% favorable impact on operating profit in the 2017 period compared to noa 4% unfavorable impact on operating profit in the 2016 period versus the 2015 period.

Other (income) expense, net

Other (income) expense, net ~~decreased $2.0~~increased $0.8 million to ~~$0.5~~$2.9 million of income in the ~~second~~third quarter of 2017 compared to ~~$2.4~~$2.1 million of income in the ~~second~~third quarter of 2016. The year-over-year ~~decrease~~increase was primarily driven by ~~unfavorable~~favorable year-over-year foreign exchange gains/(losses) in 2017.

Net income

Net income ~~decreased~~increased by ~~$6.9~~$20.5 million quarter-over-quarter to ~~$109.8~~$110.3 million for the ~~second~~third quarter of 2017 from $89.8 million in the 2016 period, driven by the factors discussed above.

Cash flows

Cash flows from operations for the ~~six~~nine months ended ~~June~~September 30, 2017 were ~~$57.9~~$199.5 million or ~~7.0%~~7.8% of sales, compared to ~~$172.3~~$341.8 million or ~~22.0%~~14.5% of sales for the ~~six~~nine months ended ~~June~~September 30, 2016. The decrease in cash flows from operations in 2017 was principally driven by payment of a litigation settlement of $56 million (as discussed in Note 13 to the Consolidated Financial Statements)~~, lower net income~~ and higher ~~incentive compensation payments~~core working capital requirements (trade receivables, inventories and accounts payable) for the 2017 period as compared to the 2016 period.

Results of Operations


	Three Months Ended June 30,								Six Months Ended June 30,								Three Months Ended September 30,								Nine Months Ended September 30,
(DOLLARS IN THOUSANDS EXCEPT PER SHARE AMOUNTS)	2017			2016			Change		2017			2016			Change		2017			2016			Change		2017			2016			Change
Net sales	$	842,861		$	793,478		6	%	$	1,671,154		$	1,576,789		6	%	$	872,940		$	777,001		12	%	$	2,544,094		$	2,353,790		8	%
Cost of goods sold	468,272			427,837			9	%	931,899			850,940			10	%	490,884			430,733			14	%	1,422,783			1,281,673			11	%
Gross profit	374,589			365,641					739,255			725,849					382,056			346,268					1,121,311			1,072,117
Research and development (R&D) expenses	70,320			63,252			11	%	140,031			126,637			11	%	70,932			64,415			10	%	210,963			191,052			10	%
Selling and administrative (S&A) expenses	135,910			132,784			2	%	276,240			256,327			8	%	141,473			152,046			(7	)%	417,713			408,372			2	%
Amortization of acquisition-related intangibles	8,494			5,130			66	%	15,561			11,191			39	%	8,766			5,468			60	%	24,327			16,659			46	%
Restructuring and other charges, net	791			—			100	%	10,934			—			100	%	3,249			—			100	%	14,183			—			100	%
Gain on sales of fixed assets	(68		)	(197		)	(65	)%	(89		)	(2,910		)	(97	)%	(31		)	(87		)	(64	)%	(120		)	(2,998		)	(96	)%
Operating profit	159,142			164,672					296,578			334,604					157,667			124,426					454,245			459,032
Interest expense	17,556			15,060			17	%	30,363			27,539			10	%	19,221			13,111			47	%	49,584			40,649			22	%
Other (income) expense	(454		)	(2,438		)	(81	)%	(14,312		)	118			(12,229	)%
Other (income) expense, net																	(2,880		)	(2,075		)	39	%	(17,192		)	(1,954		)	780	%
Income before taxes	142,040			152,050					280,527			306,947					141,326			113,390					421,853			420,337
Taxes on income	32,245			35,317			(9	)%	54,968			71,610			(23	)%	31,065			23,613			32	%	86,033			95,223			(10	)%
Net income	$	109,795		$	116,733		(6	)%	$	225,559		$	235,337		(4	)%	$	110,261		$	89,777		23	%	$	335,820		$	325,114		3	%
Diluted EPS	$	1.38		$	1.46		(5	)%	$	2.84		$	2.93		(3	)%	$	1.39		$	1.12		24	%	$	4.22		$	4.05		4	%
Gross margin	44.4		%	46.1		%	(170	)	44.2		%	46.0		%	(180	)	43.8		%	44.6		%	(80	)	44.1		%	45.5		%	(140	)
R&D as a percentage of sales	8.3		%	8.0		%	30		8.4		%	8.0		%	40		8.1		%	8.3		%	(20	)	8.3		%	8.1		%	20
S&A as a percentage of sales	16.1		%	16.7		%	(60	)	16.5		%	16.3		%	20		16.2		%	19.6		%	(340	)	16.4		%	17.3		%	(90	)
Operating margin	18.9		%	20.8		%	(190	)	17.7		%	21.2		%	(350	)	18.1		%	16.0		%	210		17.9		%	19.5		%	(160	)
Adjusted operating margin ⁽¹⁾	20.4		%	20.9		%	(50	)	20.1		%	21.1		%	(100	)	19.2		%	19.4		%	(20	)	19.8		%	20.6		%	(80	)
Effective tax rate	22.7		%	23.2		%	(50	)	19.6		%	23.3		%	(370	)	22.0		%	20.8		%	120		20.4		%	22.7		%	(230	)
Segment net sales
Flavors	$	414,323		$	379,504		9	%	$	820,487		$	752,012		9	%	$	409,800		$	366,857		12	%	$	1,230,286		$	1,118,869		10	%
Fragrances	428,538			413,974			4	%	850,667			824,777			3	%	463,140			410,144			13	%	1,313,808			1,234,921			6	%
Consolidated	$	842,861		$	793,478				$	1,671,154		$	1,576,789				$	872,940		$	777,001				$	2,544,094		$	2,353,790

(1)

Adjusted operating margin excludes ~~$12.7~~$9.6 million consisting of acquisition-related costs, ~~costs associated with product recalls, legal charges,~~ restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets for the three months ended ~~June~~September 30, 2017 and excludes ~~$1.0~~$26.7 million related to legal charges, operational improvement initiative, acquisition-relation and restructuring costs which were partially offset by gains on sales of fixed assets ~~and a favorable legal settlement~~ for the three months ended ~~June~~September 30, 2016. For the ~~six~~nine months ended ~~June~~September 30, 2017 adjusted operating margin excludes ~~$38.7~~$48.4 million consisting of acquisition-related costs, costs associated with product recalls, tax assessment, legal charges, restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets and excludes ~~a benefit of $1.8~~$24.9 million related to legal charges, operational improvement initiative, acquisition-relation and restructuring costs which were partially offset by gains on sales of fixed assets ~~and a favorable legal settlement, which were only partially offset by acquisition-related, operational improvement initiative and restructuring costs~~ for the ~~six~~nine months ended ~~June~~September 30, 2016. See "Non-GAAP Financial Measures" below.

Cost of goods sold includes the cost of materials and manufacturing expenses. R&D expenses relate to the development of new and improved products, technical product support and compliance with governmental regulations. S&A expenses include expenses necessary to support our commercial activities and administrative expenses supporting our overall operating activities.

~~SECOND~~THIRD QUARTER 2017 IN COMPARISON TO ~~SECOND~~THIRD QUARTER 2016

Sales

Sales for the ~~second~~third quarter of 2017 totaled ~~$842.9~~$872.9 million, an increase of 6%12% on a reported and currency neutral basis from the prior year quarter. ~~On a currency neutral basis sales increased 8%.~~ Sales growth reflected new win performance ~~partially offset by~~in both Flavors and Fragrances, volume growth in Fragrances and lower volume declines on existing business in ~~both Flavors and Fragrances.~~Flavors. On both a reported and currency neutral basis, acquisitions accounted for approximately 6% of the net sales growth.

Flavors Business Unit

Flavors reported sales and currency neutral sales increased 9%12% from the prior year period ~~while currency neutral sales increased 11%~~ during the ~~second~~third quarter of 2017 compared to the 2016 period. Acquisitions accounted for approximately 7% of the net sales growth on a reported basis and ~~approximately 8%~~ on a currency neutral basis. Sales growth excluding acquisitions reflected new win performance ~~which was partially offset by~~and lower volume declines on existing business. Overall growth was primarily driven by low to high single-digit growth in all four Flavors end-use categories. The Flavors business delivered sales growth in NOAM, LAEAME and ~~EAME,~~GA, led by NOAM, and experienced flat sales ~~declines~~growth in ~~GA.~~LA. Sales in NOAM, which included the impact of acquisitions, were led by ~~high single-digit~~double-digit growth in ~~Savory. LA sales were led by double-digit gains in~~ Savory ~~and Sweet and high single-digit gains in Beverage. Sales in EAME were driven by high single-digit gains in Dairy and mid single-digit gains in Beverage and Sweet. GA sales declines were driven by~~which more than offset mid to high single-digit declines in Sweet and Dairy. Sales in EAME were driven by double-digit gains in Beverage and Dairy and mid single-digit gains in Savory and Sweet. GA sales growth was driven by mid to high single-digit growth in Savory and Sweet. LA flat sales growth included double-digit gains in Dairy and high single-digit gains in Savory which were offset by low single-digit declines in Beverage.

Fragrances Business Unit

Fragrances sales increased 4%13% on a reported basis and 5%12% on a currency neutral basis for the ~~second~~third quarter of 2017 compared to the ~~second~~third quarter of 2016. Acquisitions accounted for approximately 4%5% of both reported and currency neutral sales growth. Excluding the effect of acquisitions, reported sales ~~were flat reflecting~~growth reflected new win performance ~~offset by~~and volume ~~declines~~growth on existing business. Net sales reflected double-digit growth in ~~Fine Fragrances and~~Home Care, high single-digit growth in Fabric Care and Fragrance Ingredients as well as mid single-digit growth in Fine Fragrances, which ~~were~~more than offset ~~by double-digit declines in Hair Care and~~ high single-digit declines in ~~Toiletries.~~Hair Care.

Sales Performance by Region and Category


		% Change in Sales - Second Quarter 2017 vs. Second Quarter 2016													% Change in Sales - Third Quarter 2017 vs. Third Quarter 2016
		Fine Fragrances		Consumer Fragrances		Ingredients		Total Frag.		Flavors		Total			Fine Fragrances		Consumer Fragrances		Ingredients		Total Frag.		Flavors		Total
NOAM	Reported	12	%	7	%	2	%	7	%	30	%	19	%	Reported	12	%	10	%	-4	%	7	%	28	%	18	%
EAME	Reported	15	%	4	%	8	%	8	%	2	%	6	%	Reported	28	%	17	%	18	%	20	%	12	%	17	%
	Currency Neutral ⁽¹⁾	19	%	8	%	11	%	12	%	9	%	11	%	Currency Neutral ⁽¹⁾	25	%	14	%	16	%	18	%	12	%	15	%
LA	Reported	-5	%	-5	%	35	%	-2	%	13	%	3	%	Reported	14	%	13	%	37	%	15	%	0	%	9	%
	Currency Neutral ⁽¹⁾	-7	%	-6	%	34	%	-4	%	11	%	1	%	Currency Neutral ⁽¹⁾	10	%	13	%	37	%	14	%	1	%	9	%
GA	Reported	23	%	-3	%	1	%	-2	%	-3	%	-3	%	Reported	13	%	8	%	-1	%	6	%	2	%	4	%
	Currency Neutral ⁽¹⁾	25	%	-2	%	3	%	-1	%	-2	%	-1	%	Currency Neutral ⁽¹⁾	14	%	8	%	0	%	7	%	2	%	4	%
Total	Reported	10	%	0	%	7	%	4	%	9	%	6	%	Reported	20	%	12	%	9	%	13	%	12	%	12	%
	Currency Neutral ⁽¹⁾	11	%	1	%	9	%	5	%	11	%	8	%	Currency Neutral ⁽¹⁾	18	%	11	%	8	%	12	%	12	%	12	%


(1)	Currency neutral sales growth is calculated by translating prior year sales at the exchange rates for the corresponding 2017 period.

NOAM Flavors sales growth ~~which~~ included the impact of acquisitions and primarily reflected double-digit growth in Savory and low single-digit growth in ~~all four end-use~~Beverage, which more than offset mid to high single-digit declines in Sweet and Dairy categories. Total Fragrances sales growth included the impact of acquisitions and reflected double-digit gains in Fine Fragrances ~~mid to~~and high single-digit gains in Fabric Care and Home Care ~~and low single-digit gains in Fragrance Ingredients,~~ which ~~were only partially~~more than offset by double-digit declines in ~~Hair Care.~~Personal Wash and mid single-digit declines in Fragrance Ingredients.

EAME Flavors sales experienced ~~high single-digit~~double-digit gains in Beverage and Dairy and mid single-digit gains in ~~Beverage~~Savory and Sweet. Total Fragrances sales growth included the impact of acquisitions and was driven mainly by double-digit growth in Fine Fragrances, Home Care and Fragrance Ingredients as well as ~~high single-digit growth in Fragrance Ingredients and low~~mid single-digit growth in Fabric Care which more than offset ~~double-digit declines in Toiletries and~~ high single-digit declines in Hair Care and low single-digit declines in Personal Wash and Toiletries.

LA Flavors sales included double-digit gains in Dairy and high single-digit gains in Savory which were offset by low single-digit declines in Beverage. Total Fragrances sales growth included the impact of acquisitions and reflected double-digit gains in Fragrance Ingredients, Home Care, Personal Wash and Fine Fragrances as well as high single-digit gains in Fabric Care.

LAGA Flavors sales growth was driven by ~~double-digit gains~~mid to high single-digit growth in Savory and Sweet, ~~and high single-digit gains in Beverage. Total Fragrances sales declines reflected double-digit gains in Fragrance Ingredients,~~ which were ~~more than~~only partially offset by ~~double-digit declines in Personal Wash and Hair Care as well as high single-digit declines in Fine Fragrances and~~ mid to low single-digit declines in ~~Home Care and Fabric Care.~~

~~GA Flavors sales declines were driven by mid to high single-digit declines in Sweet~~Beverage and Dairy. Total Fragrances sales ~~declines were~~growth included the impact of acquisitions and was principally driven by double-digit gains in Fine Fragrances, Fabric Care and Home Care and high single-digit gains in Toiletries, which more than offset mid single-digit declines in Hair Care and low single-digit ~~gains~~declines in Fragrance ~~Ingredients which were more than offset by double-digit declines in Personal Wash and Hair Care.~~Ingredients.

Cost of Goods Sold

Cost of goods sold, as a percentage of sales, increased ~~170~~80 bps to ~~55.6%~~56.2% in the ~~second~~third quarter of 2017 compared to ~~53.9%~~55.4% in the ~~second~~third quarter of 2016, principally driven by unfavorable price versus input costs and ~~manufacturing performance~~mix which were only partially offset by cost savings and productivity initiatives and the impact of acquisitions. Included in cost of goods sold were ~~$9.6~~$5.7 million of acquisition-related amortization of inventory "step-up" costs, ~~costs associated with product recalls,~~ operational improvement initiative and integration-related costs in 2017 compared to $1.0 million of ~~acquisition-related amortization of inventory "step-up" costs,~~ operational improvement initiative ~~costs~~ and restructuring costs in 2016.

Research and Development (R&D) Expenses

Overall R&D expenses, as a percentage of sales, ~~increased~~decreased slightly ~~compared to the prior year period~~ to ~~8.3%~~8.1% in the ~~second~~third quarter of 2017 versus ~~8.0%~~8.3% in the ~~second~~third quarter of 2016. ~~This increase was primarily driven by costs associated with R&D of acquired entities.~~

Selling and Administrative (S&A) Expenses

S&A expenses ~~increased $3.1~~decreased $10.6 million to ~~$135.9~~$141.5 million or ~~16.1%~~16.2%, as a percentage of sales, in the ~~second~~third quarter of 2017 compared to ~~$132.8~~$152.0 million or ~~16.7%~~19.6%, as a percentage of sales, in the ~~second~~third quarter of 2016. The ~~$3.1~~$10.6 million ~~increase~~decrease was principally due to lower costs associated with acquisitions in 2017. Included in 2017 was approximately $0.7 million of acquisition-related and integration-related costs. Excluding the $0.7 million included in 2017 and $25.8 million of legal charges, acquisition-related and operational improvement initiative costs in 2016, adjusted S&A expenses increased by $14.6 million and was 16.1% of sales in 2017 compared to 16.2% of sales in 2016 principally due to costs associated with S&A expenses of acquired entities and approximately $2.2 million of legal charges, acquisition-related and integration-related costs in 2017. Excluding the $2.2 million included in 2017 and $0.2 million of acquisition-related costs which were only partially offset by credits related to adjustment of a legal reserve in 2016, adjusted S&A expenses increased by $1.1 million and was 15.9% of sales in 2017 compared to 16.7% of sales in 2016.entities.

Restructuring and Other Charges

2017 Productivity Program

During the ~~second~~third quarter of 2017, the Company recorded ~~$3.1~~$3.2 million of charges related to personnel-related costs and lease termination costs, with the remainder of the personnel-related and other costs expected to be recognized by the end of ~~2017 and the other costs expected to be recognized over the following six quarters.~~2018. During the ~~second~~third quarter of 2017, the Company made payments of ~~$4.5~~$3.5 million related to severance. The overall charges were split approximately evenly between Flavors and Fragrances. This initiative is expected to result in the reduction of approximately 370 members of the Company’s global workforce in various parts of the organization. Once fully implemented, the Company expects to realize annual run-rate savings of between $40 million and $45 million from this program by 2019.

~~2015 Severance Charges~~

During 2015, the Company established a series of initiatives intended to streamline its management structure, simplify decision-making and accountability, better leverage and align its capabilities across the organization and improve efficiency of its global manufacturing and operations network. As a result, the Company recorded charges for severance and related costs pertaining to approximately 150 positions that were affected. During the second quarter of 2017, the Company recorded a credit of $2.3 million related to the reversal of severance accruals that were determined to be no longer required. No further actions are expected related to these 2015 initiatives.

Amortization of Acquisition-Related Intangibles

Amortization expenses increased to ~~$8.5~~$8.8 million in the ~~second~~third quarter of 2017 compared to ~~$5.1~~$5.5 million in the ~~second~~third quarter of 2016. The increase was principally driven by the acquisitions of Fragrance Resources and PowderPure in 2017 and David Michael during the second half of 2016.

Operating Results by Business Unit

We evaluate the performance of business units based on segment profit which is defined as operating profit before Restructuring and other charges, net, Global expenses (as discussed in Note 9 to the Consolidated Financial Statements) and certain non-recurring items, net, Interest expense, Other (expense) income, net and Taxes on income. See Note 9 to the Consolidated Financial Statements for the reconciliation to Income before taxes.


	Three Months Ended June 30,						Three Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016
Segment profit:
Flavors	$	100,338		$	90,337		$	91,378		$	77,512
Fragrances	84,860			87,596			93,528			85,010
Global expenses	(13,398		)	(12,268		)	(17,598		)	(11,405		)
Restructuring and other charges, net	(791		)	(182		)	(3,249		)	(190		)
Acquisition and related costs	(6,278		)	(213		)	(5,436		)	(786		)
Operational improvement initiative costs	(445		)	(831		)	(407		)	(802		)
Legal (charges) credits	(1,000		)	36			—			(25,000		)
Gain on sales of assets	68			197			31			87
Tax assessment	19			—
Integration-related costs	(731		)	—			(580		)	—
FDA mandated product recall	(3,500		)	—
Operating profit	159,142			164,672			157,667			124,426
Profit margin:
Flavors	24.2		%	23.8		%	22.3		%	21.1		%
Fragrances	19.8		%	21.2		%	20.2		%	20.7		%
Consolidated	18.9		%	20.8		%	18.1		%	16.0		%

Flavors Segment Profit

Flavors segment profit increased to ~~$100.3~~$91.4 million in the ~~second~~third quarter of 2017, or ~~24.2%~~22.3% as a percentage of sales, compared to ~~$90.3~~$77.5 million, or ~~23.8%~~21.1% as a percentage of sales, in the comparable 2016 period. The increase principally reflected ~~favorable~~ volume ~~and~~growth, costs savings and productivity initiatives and the impact of acquisitions which were only partially offset by unfavorable ~~manufacturing variances and~~ mix.

Fragrances Segment Profit

Fragrances segment profit ~~decreased~~increased approximately ~~3.1%~~10.0% to ~~$84.9~~$93.5 million in the ~~second~~third quarter of 2017, or ~~19.8%~~20.2% as a percentage of sales, compared to ~~$87.6~~$85.0 million, or ~~21.2%~~20.7% as a percentage of sales, in the comparable 2016 period. The ~~decrease~~increase in segment profit ~~and profit margin~~ was primarily due to volume growth, cost savings and productivity initiatives and the impact of acquisitions which more than offset unfavorable price versus input ~~cost and the impact from acquisitions which was only partially offset by the cost savings and productivity initiatives.~~costs.

Global Expenses

Global expenses represent corporate and headquarters-related expenses which include legal, finance, human resources and R&D and other administrative expenses that are not allocated to an individual business unit. In the ~~second~~third quarter of 2017, Global expenses were ~~$13.4~~$17.6 million compared to ~~$12.3~~$11.4 million during the ~~second~~third quarter of 2016. The increase was principally driven by ~~lower~~higher incentive compensation expense which was only partially offset by higher benefits from our currency hedging ~~program and higher incentive compensation expense.~~

program.

Interest Expense

Interest expense increased to $~~17.6~~19.2 million in the ~~second~~third quarter of 2017 compared to ~~$15.1~~$13.1 million in the 2016 period reflecting the issuance of the Senior Notes - 2017. Average cost of debt was ~~4.1%~~4.3% for the 2017 period compared to ~~4.0%~~3.7% for the 2016 period.

Other (Income) Expense, Net

Other (income) expense, net ~~decreased~~increased by approximately ~~$2.0~~$0.8 million to ~~$0.5~~$2.9 million of income in the ~~second~~third quarter of 2017 versus ~~$2.4~~$2.1 million of income in the comparable 2016 period. The year-over-year ~~decrease~~increase was primarily driven by ~~unfavorable~~favorable year-over-year foreign exchange gains/(losses) in 2017.

Income Taxes

The effective tax rate for the three months ended ~~June~~September 30, 2017 was ~~22.7%~~22.0% compared with ~~23.2%~~20.8% for the three months ended ~~June~~September 30, 2016. The quarter-over-quarter ~~decrease~~increase was largely due to ~~a more favorable mix of earnings and~~higher repatriation costs partially offset by the impact of the global supply chain hub ~~offset by unfavorable repatriation costs~~and mix of earnings as compared to the prior year. Excluding ~~$3.3~~$3.2 million of benefits associated with the pre-tax acquisition-related costs, ~~costs associated with product recalls, legal charges,~~ restructuring, integration-related and operational improvement initiative costs, as partially offset by the tax charge associated with gains on sales of fixed assets in the current quarter, the ~~second~~third quarter 2017 adjusted effective tax rate was ~~23.0%~~22.7%, or 1070 bps lower than the ~~second~~third quarter 2016 adjusted effective tax rate of ~~23.1%~~23.4%. The 2016 adjusted effective tax rate excluded ~~$0.1~~$9.2 million of tax benefit associated with legal charges, acquisition related costs, restructuring and operational improvement initiative costs which were only partially offset by tax charges associated with ~~acquisition related costs and~~ gains on the sales of fixed ~~assets and a favorable legal settlement.~~assets.

As a result of the adoption of ~~ASU 2016-09,~~new accounting guidance on the tax effect of stock compensation vesting, as discussed in Note 1 to our Consolidated Financial Statements, current income tax expense now includes the tax benefit of equity award vestings of ~~$2.4~~less than $0.1 million for the three months ended ~~June~~September 30, 2017.

FIRST ~~SIX~~NINE MONTHS 2017 IN COMPARISON TO FIRST ~~SIX~~NINE MONTHS 2016

Sales

Sales for the first ~~six~~nine months of 2017 totaled ~~$1,671.2 million,~~$2.5 billion, an increase of 6%8% from the 2016 period. On a currency neutral basis sales increased 7%9%. Sales growth reflected new win performance partially offset by volume declines on existing business in both Flavors and Fragrances and unfavorable pricing in Fragrances. On both a reported and currency neutral basis, acquisitions accounted for approximately 5%6% of the net sales growth.

Flavors Business Unit

Flavors sales increased 9%10% on a reported basis and increased 11% on a currency neutral basis during the first ~~six~~nine months of 2017 compared to the 2016 period. Acquisitions accounted for approximately 7% of the net sales growth on both a reported and currency neutral basis. Sales growth excluding acquisitions reflected new win performance which was partially offset by volume declines on existing business. Overall growth was primarily driven by low to ~~high~~mid single-digit growth in all four end-use categories. The Flavors business delivered sales growth in NOAM, LA and EAME, led by NOAM and ~~experienced declines~~delivered flat sales growth in GA. Sales growth in NOAM, which included the impact of acquisitions, ~~were~~was led by double-digit growth in Savory and mid single-digit growth in Dairy. LA sales growth was led by double-digit gains in Savory and Dairy and ~~high~~mid to low single-digit gains in ~~Sweet.~~Sweet and Beverage. Sales in EAME were driven by mid to high single-digit gains in ~~Savory and Sweet.~~all categories. GA sales experienced ~~mid~~low single-digit gains in Savory and Beverage which were ~~more than~~ offset by ~~high~~mid single-digit declines in ~~Dairy and low single-digit declines in Sweet.~~Dairy.

Fragrances Business Unit

Fragrances sales increased 3%6% on a reported basis and 4%7% on a currency neutral basis for the first ~~six~~nine months of 2017 compared to the 2016 period. Acquisitions accounted for approximately 4%5% of both reported and currency neutral sales growth. Excluding the effect of acquisitions, reported sales ~~declines~~growth reflected new win performance which ~~was~~ more than offset by volume declines on existing business and unfavorable price versus input costs. Net sales reflected double-digit gains in Fine Fragrances and mid single-digit gains in Fragrance Ingredients, ~~and low single-digit growth in~~ Fabric Care and Home Care, which ~~were~~ more than offset by double-digit declines in Hair Care and ~~mid~~low single-digit declines in ~~Toiletries and Personal Wash.~~Toiletries.

Sales Performance by Region and Category


		% Change in Sales - First Six Months 2017 vs. First Six Months 2016													% Change in Sales - First Nine Months 2017 vs. First Nine Months 2016
		Fine Fragrances		Consumer Fragrances		Ingredients		Total Frag.		Flavors		Total			Fine Fragrances		Consumer Fragrances		Ingredients		Total Frag.		Flavors		Total
NOAM	Reported	10	%	6	%	-4	%	4	%	28	%	17	%	Reported	11	%	7	%	-4	%	5	%	28	%	17	%
EAME	Reported	18	%	4	%	10	%	10	%	1	%	6	%	Reported	21	%	9	%	12	%	13	%	5	%	10	%
	Currency Neutral ⁽¹⁾	22	%	8	%	13	%	13	%	7	%	11	%	Currency Neutral ⁽¹⁾	22	%	10	%	13	%	14	%	9	%	12	%
LA	Reported	-9	%	-7	%	25	%	-5	%	11	%	0	%	Reported	-1	%	-1	%	30	%	1	%	7	%	3	%
	Currency Neutral ⁽¹⁾	-14	%	-7	%	24	%	-7	%	8	%	-1	%	Currency Neutral ⁽¹⁾	-5	%	-1	%	29	%	0	%	6	%	2	%
GA	Reported	18	%	0	%	-6	%	0	%	-1	%	0	%	Reported	19	%	3	%	-4	%	2	%	0	%	1	%
	Currency Neutral ⁽¹⁾	20	%	1	%	-4	%	1	%	0	%	0	%	Currency Neutral ⁽¹⁾	20	%	3	%	-3	%	3	%	1	%	2	%
Total	Reported	10	%	1	%	4	%	3	%	9	%	6	%	Reported	13	%	4	%	5	%	6	%	10	%	8	%
	Currency Neutral ⁽¹⁾	11	%	2	%	5	%	4	%	11	%	7	%	Currency Neutral ⁽¹⁾	13	%	5	%	6	%	7	%	11	%	9	%


(1)	Currency neutral sales growth is calculated by translating prior year sales at the exchange rates for the corresponding 2017 period.

NOAM Flavors sales growth, which included the impact of acquisitions, ~~were~~was led by double-digit growth in Savory and mid single-digit growth in Dairy. Total Fragrances sales growth ~~which~~ included the impact of acquisitions and reflected double-digit gains in Fine Fragrances, ~~and~~ mid to high single-digit ~~growth~~gains in Home Care and Fabric Care which ~~was partially~~more than offset bydouble-digit declines in Personal Wash, high single-digit declines in Hair Care and mid single-digit declines in Fragrance Ingredients.

EAME Flavors sales experienced mid to high single-digit gains in ~~Savory and Sweet.~~all categories. Total Fragrances sales growth ~~which~~ included the impact of acquisitions and was driven mainly by double-digit growth in Fine Fragrances and Fragrance Ingredients as well as mid single-digit growth in Home Care.

LA Flavors sales growth was driven by double-digit gains in Savory and Dairy and ~~high~~mid to low single-digit gains in ~~Sweet.~~Sweet and Beverage. Total Fragrances sales ~~declines~~growth reflected double-digit gains in Fragrance Ingredients and mid single-digit gains in Home Care, which ~~were~~ more than offset by double-digit declines in Hair Care and ~~Personal Wash and~~ low ~~to high~~ single-digit declines in ~~Fabric Care and Home Care.~~Fine Fragrances.

GA Flavors sales ~~declines~~experienced low single-digit gains in Savory and Beverage which were ~~driven~~offset by mid single-digit ~~gains in Beverage which were more than offset by high single-digit~~ declines in ~~Dairy and low single-digit declines in Sweet.~~Dairy. Total Fragrances ~~flat~~ sales growth included the impact of acquisitions and principally reflected double-digit gains in Fine Fragrances and ~~low~~mid single-digit ~~growth~~gains in Fabric Care and Home Care, which ~~were~~more than offset by mid single-digit declines in Fragrance Ingredients and Hair ~~Care and Personal Wash.~~Care.

Cost of Goods Sold

Cost of goods sold, as a percentage of sales, increased ~~180~~140 bps to ~~55.8%~~55.9% in the first ~~six~~nine months of 2017 compared to ~~54.0%~~54.5% in the 2016 period, principally driven by unfavorable manufacturing performance and price versus input costs which were only partially offset by cost savings and productivity initiatives and the impact of acquisitions. Included in cost of goods sold were ~~$15.7~~$21.3 million of acquisition-related amortization of inventory "step-up", costs associated with product recalls, operational improvement initiative and integration-related costs in 2017 compared to ~~$2.3~~$3.3 million of acquisition-related amortization of inventory "step-up", operational improvement initiative and restructuring costs in 2016.

Research and Development (R&D) Expenses

Overall R&D expenses, as a percentage of sales, increased ~~compared~~ to ~~the prior year period to 8.4%~~8.3% in the first ~~six~~nine months of 2017 versus ~~8.0%~~8.1% in the 2016 period. This increase was primarily driven by costs associated with R&D of acquired entities.

Selling and Administrative (S&A) Expenses

S&A expenses increased ~~$19.9~~$9.3 million to ~~$276.2~~$417.7 million or ~~16.5%~~16.4%, as a percentage of sales, in the first ~~six~~nine months of 2017 compared to ~~16.3%~~17.3% in the 2016 period. The ~~$19.9~~$9.3 million increase was principally due to costs associated with S&A expenses of acquired entities and approximately ~~$12.0~~$12.6 million of expense related to a tax assessment from prior year, legal charges and acquisition-related and integration-related costs in 2017. Excluding the ~~$12.0~~$12.6 million included in 2017 and ~~the benefit of $1.1~~$24.7 million of ~~credits related to~~ legal ~~credits which were only partially offset by~~charges and acquisition-related costs in 2016, adjusted S&A expenses increased by ~~$6.8~~$21.4 million and was ~~15.8%~~15.9% of sales in 2017 compared to 16.3% in ~~2016.~~2016 principally due to costs associated with S&A expenses of acquired entities.

Restructuring and Other Charges

2017 Productivity Program

During the first ~~six~~nine months of 2017, the Company recorded charges of ~~$13.2~~$16.5 million related to personnel-related costs and lease termination costs and made payments of ~~$6.8~~$10.0 million related to severance. The overall charges were split approximately evenly between Flavors and Fragrances. This initiative is expected to result in the reduction of approximately 370 members of the Company’s global workforce in various parts of the organization. Once fully implemented, the Company expects to realize annual run-rate savings of between $40 million and $45 million from this program by 2019.

2015 Severance Charges

During the first ~~six~~nine months of 2017, the Company made payments of $0.2 million related to severance and recorded a credit of $2.3 million related to the reversal of severance accruals that were determined to be no longer required. No further actions are expected in 2017 related to these 2015 initiatives.

Amortization of Acquisition-Related Intangibles

Amortization expenses increased to ~~$15.6~~$24.3 million in the first ~~six~~nine months of 2017 compared to ~~$11.2~~$16.7 million in the 2016 period. The increase was principally driven by the acquisitions of Fragrance Resources and PowderPure in 2017 and David Michael during the second half of 2016.

Operating Results by Business Unit


	Six Months Ended June 30,						Nine Months Ended September 30,
(DOLLARS IN THOUSANDS)	2017			2016			2017			2016
Segment profit:
Flavors	$	198,346		$	182,151		$	289,723		$	259,662
Fragrances	166,557			176,833			260,085			261,843
Global expenses	(29,594		)	(26,141		)	(47,193		)	(37,544		)
Restructuring and other charges, net	(10,934		)	(283		)	(14,183		)	(473		)
Acquisition and related costs	(15,066		)	(1,249		)	(20,502		)	(2,035		)
Operational improvement initiative costs	(1,066		)	(1,099		)	(1,473		)	(1,901		)
Legal (charges) credits	(1,000		)	1,482			(1,000		)	(23,518		)
Gain on sales of assets	89			2,910			120			2,998
Tax assessment	(5,331		)	—			(5,331		)	—
Integration-related costs	(1,923		)	—			(2,501		)	—
FDA mandated product recall	(3,500		)	—			(3,500		)	—
Operating profit	296,578			334,604			454,245			459,032
Profit margin:
Flavors	24.2		%	24.2		%	23.5		%	23.2		%
Fragrances	19.6		%	21.4		%	19.8		%	21.2		%
Consolidated	17.7		%	21.2		%	17.9		%	19.5		%

Flavors Segment Profit

Flavors segment profit increased to ~~$198.3~~$289.7 million in the first ~~six~~nine months of 2017, or ~~24.2%~~23.5% as a percentage of sales, compared to ~~$182.2~~$259.7 million, or ~~24.2%~~23.2% as a percentage of sales, in the comparable 2016 period. The increase in segment profit principally reflected favorable volume and costs savings and productivity initiatives which were only partially offset by unfavorable price versus input costs as well as a reserve for a product liability sales allowance.

Fragrances Segment Profit

Fragrances segment profit decreased to ~~$166.6~~$260.1 million in the first ~~six~~nine months of 2017, or ~~19.6%~~19.8% as a percentage of sales, compared to ~~$176.8~~$261.8 million, or ~~21.4%~~21.2% as a percentage of sales, in the comparable 2016 period. The decrease in segment profit and profit margin was primarily due to unfavorable price versus input cost and the impact of acquisitions which was only partially offset by the cost savings and productivity initiatives.

Global Expenses

Global expenses represent corporate and headquarters-related expenses which include legal, finance, human resources and R&D and other administrative expenses that are not allocated to an individual business unit. In the first ~~six~~nine months of 2017, Global expenses were ~~$29.6~~$47.2 million compared to ~~$26.1~~$37.5 million during the first ~~six~~nine months of 2016. The increase was principally driven by lower benefits from our currency hedging program and ~~slightly~~ higher incentive compensation expense.

Interest Expense

Interest expense increased to ~~$30.4~~$49.6 million in the first ~~six~~nine months of 2017 compared to ~~$27.5~~$40.6 million in the 2016 period reflecting the issuance of the Senior Notes - 2017. Average cost of debt was 3.8% for both the 2017 ~~period compared to 3.9% for the~~and 2016 ~~period.~~periods.

Other (Income) Expense, Net

Other (income) expense, net increased by approximately ~~$14.4~~$15.2 million to ~~$14.3~~$17.2 million of income in the first ~~six~~nine months of 2017 versus ~~$0.1~~$2.0 million of ~~expense~~income in the comparable 2016 period. The year-over-year increase was primarily driven by the release of a currency translation adjustment (CTA) of $12.2 million related to the liquidation of a foreign entity in the first quarter of 2017.

Income Taxes

The effective tax rate for the ~~six~~nine months ended ~~June~~September 30, 2017 was ~~19.6%~~20.4% compared with ~~23.3%~~22.7% for the ~~six~~nine months ended ~~June~~September 30, 2016. The year-over-year decrease was primarily due to ~~various items (including~~ certain non-taxable gains on foreign currency and the impact of adopting the new accounting guidance on the tax effect of stock compensation ~~vesting),~~vesting, a more favorable mix of earnings and the impact of the global supply chain hub, offset by unfavorable repatriation costs as compared to the prior year. Excluding ~~$11.8~~$15.0 million of tax benefits associated with pre-tax restructuring, acquisition-related, cost associated with product ~~liability,~~recall, integration-related, ~~and~~legal charges, operational improvement initiative costs ~~as well as~~and a tax assessment which were only partially offset by the tax charge associated with gains on sales of fixed assets and the non-taxable gains on foreign currency in the first quarter, the first ~~six~~nine months 2017 adjusted effective tax rate was ~~21.8%~~22.1%, or ~~150~~130 bps lower than the first ~~six~~nine months 2016 adjusted effective tax rate of ~~23.3%~~23.4%. The 2016 adjusted effective tax rate excluded ~~$0.5~~$8.8 million of tax ~~charges~~benefits associated with legal charges, acquisition-related, operational improvement initiative and restructuring costs which more than offset gains on tax charges related to pre-tax sales of fixed ~~assets and a favorable legal settlement which were only partially offset by tax benefits related to the pre-tax acquisition-related, restructuring and operational improvement initiative costs.~~assets.

As a result of the adoption of ~~ASU 2016-09,~~new accounting guidance on the tax effect of stock compensation vesting, as discussed in Note 1 to our Consolidated Financial Statements, current income tax expense now includes the tax benefit of equity award vestings of $3.2 million for the ~~six~~nine months ended ~~June~~September 30, 2017. In recent years, the tax benefit on these vestings was $4.5 million, $9.9 million and $5.3 million in fiscal 2014, 2015 and 2016, respectively.

Liquidity and Capital Resources

Cash and Cash Equivalents

We had cash and cash equivalents of ~~$491.4~~$316.0 million at ~~June~~September 30, 2017 compared to $324.0 million at December 31, 2016, of which ~~$198.5~~$201.2 million of the balance at ~~June~~September 30, 2017 was held outside the United States. Cash balances held in foreign jurisdictions are, in most circumstances, available to be repatriated to the United States; however, they would be subject to United States federal income taxes, less applicable foreign tax credits. We have not provided U.S. income tax expense on substantially all of the accumulated undistributed earnings of our foreign subsidiaries because we have the ability and plan to reinvest these indefinitely.

Effective utilization of the cash generated by our international operations is a critical component of our tax strategy. Strategic dividend repatriation from foreign subsidiaries creates U.S. taxable income, which enables us to realize deferred tax assets. The Company regularly repatriates, in the form of dividends from its non-U.S. subsidiaries, a portion of its current year earnings to fund financial obligations in the U.S.

Cash Flows Provided By Operating Activities

Net cash from operating activities in the first ~~six~~nine months of 2017 was ~~$57.9~~$199.5 million compared to ~~$172.3~~$341.8 million in the first ~~six~~nine months of 2016. The decrease in cash from operating activities for the first ~~six~~nine months of 2017 compared to 2016 was principally driven by payment of a litigation settlement of $56 million (as discussed in Note 13 to the Consolidated Financial Statements)~~, lower net income~~ and higher ~~incentive compensation payments~~core working capital requirements for the 2017 period as compared to 2016 period.

Working capital (current assets less current liabilities) totaled ~~$1,132.7~~$1,153.6 million at ~~June~~September 30, 2017, compared to $710.7 million at December 31, ~~2016 reflecting higher cash balances as a result of proceeds from the Senior Notes - 2017.~~2016. The Company sold certain accounts receivable on a non-recourse basis to unrelated financial institutions under “factoring” agreements that are sponsored, solely and individually, by certain customers. We believe that participating in the factoring programs strengthens our relationships with these customers and provides operational efficiencies. The beneficial impact on cash provided by operations from participating in these programs ~~decreased~~increased approximately ~~$4.7~~$12.1 million for the ~~six~~nine months ended ~~June~~September 30, 2017 compared to an increase of approximately ~~$17.7~~$25.8 million for the ~~six~~nine months ended ~~June~~September 30, 2016. The cost of participating in these programs was immaterial to our results in all periods.

Cash Flows Used In Investing Activities

Net investing activities during the first ~~six~~nine months of 2017 used ~~$232.0~~$263.2 million compared to ~~$40.2~~$66.2 million in the prior year period. The increase in cash used in investing activities principally reflected the acquisition of Fragrance Resources and PowderPure in 2017 for approximately $136.0 million and $54.7 million (net of cash acquired), respectively. Additions to property, plant and equipment were ~~$46.2~~$77.3 million during the first ~~six~~nine months of 2017 compared to ~~$43.2~~$70.2 million in the first ~~six~~nine months of 2016. We expect additions to property, plant and equipment will be approximately 4.5% ~~- 5%~~ of our sales (net of potential grants and other reimbursements from government authorities) in 2017.

Cash Flows Provided By Financing Activities

Net financing activities in the first ~~six~~nine months of 2017 increased to ~~$343.6~~$57.5 million compared to ~~$235.4~~$53.3 million of cash inflows in the first ~~six~~nine months of 2016, principally driven by ~~higher proceeds from the revolving credit facility and the issuance of the Senior Notes - 2017 as well as~~ lower share repurchases which were only partially offset by higher dividend payments in the 2017 period compared to the 2016 ~~period, which included the issuance of the Euro Senior Notes - 2016.~~period.

At ~~June~~September 30, 2017, we had ~~$1,894.2~~$1,673.3 million of debt outstanding compared to $1,325.4 million outstanding at December 31, 2016.

During the third quarter of 2017, the Company made a payment of $250 million on the Senior Notes - 2007.

We paid dividends totaling ~~$101.2~~$151.7 million in the 2017 period. We declared a cash dividend per share of ~~$0.64~~$0.69 in the ~~second~~third quarter of 2017 that was paid on ~~July 7,~~October 6, 2017 to all shareholders of record as of ~~June 26,~~September 25, 2017. ~~In August 2017, the Board of Directors approved an increase in our quarterly dividend for the third quarter of 2017 by 8%, to $0.69 per share.~~

In December 2012, the Board of Directors authorized a $250 million share repurchase program, which commenced in the first quarter of 2013. In August 2015, the Board of Directors approved an additional $250 million share repurchase authorization and extension through December 31, 2017. Based on the total remaining amount of $56.1 million available under the amended repurchase program, approximately 0.4 million shares, or 0.5% of shares outstanding (based on the market price and shares outstanding as of ~~June~~September 30, 2017) could be repurchased under the program as of ~~June~~September 30, 2017. No shares were repurchased during the three months ended September 30, 2017. During the ~~three~~nine months ended ~~June 30, 2017, we repurchased 114,930 shares on the open market at an aggregate cost of $15.6 million or an average of $135.7 per share. During the six months ended June~~September 30, 2017, we repurchased 427,219 shares on the open market at an aggregate cost of $53.2 million or an average of $124.6 per share. The ~~purchases~~repurchases will be made from time to time on the open market or through private transactions as market and business conditions warrant. Repurchased shares will be placed into treasury stock. The ultimate level of purchases will be a function of the daily purchase limits established in the pre-approved program according to the share price at that time. In November 2017, the Board of Directors approved an additional $300 million share repurchase authorization and extension through December 31, 2022.

Capital Resources

Operating cash flow provides the primary source of funds for capital investment needs, dividends paid to shareholders and debt repayments. We anticipate that cash flows from operations and availability under our existing credit facilities are sufficient to meet our investing and financing needs for at least the next eighteen months. We regularly assess our capital structure, including both current and long-term debt instruments, as compared to our cash generation and investment needs in order to provide ample flexibility and to optimize our leverage ratios. We believe our existing cash balances are sufficient to meet our debt service requirements.

We supplement short-term liquidity with access to capital markets, mainly through bank credit facilities and issuance of commercial paper. Commercial paper issued by the Company generally has terms of 90 days or less. The maximum commercial

paper borrowings outstanding during the first, second and ~~second~~third quarters of 2017 were approximately $107.5 million, $50 million and ~~$50~~$40 million, respectively. As of ~~June~~September 30, 2017, there was no$40.0 million of commercial paper outstanding. The revolving credit facility is used as a backstop for the Company's commercial paper program. No commercial paper was issued during the ~~six~~nine months ended ~~June~~September 30, 2016.

We expect to contribute a total of approximately $2$3 - $10 million to our U.S. pension plans during 2017. During the ~~six~~nine months ended ~~June~~September 30, 2017, no contributions were made to our qualified U.S. pension plans and ~~$29.3~~$33.6 million contributions were made to our non-U.S. pension plans.

As of ~~June~~September 30, 2017, we had ~~$28.4 million~~no of borrowings under our revolving credit facility. The amount which we are able to draw down on under the facility is limited by financial covenants as described in more detail below. Our draw down capacity on the facility was ~~$921.6~~$950.0 million at ~~June~~September 30, ~~2017. We expect interest expense to increase in the third quarter of 2017 as a result of a full quarter of interest related to the Senior Notes -~~ 2017.

Under our revolving credit facility, we are required to maintain, at the end of each fiscal quarter, a ratio of net debt for borrowed money to adjusted EBITDA in respect of the previous 12-month period of not more than 3.5 to 1. Based on this ratio, at ~~June~~September 30, 2017 our covenant compliance provided overall borrowing capacity of ~~$1,279~~$1,404 million.

At ~~June~~September 30, 2017, we were in compliance with all financial and other covenants, including the net debt to adjusted EBITDA ratio. At ~~June~~September 30, 2017 our Net Debt/adjusted EBITDA ⁽¹⁾ ratio, as defined by the debt agreements, was ~~1.83~~1.72 to 1, well below the financial covenants of existing outstanding debt. Failure to comply with the financial and other covenants under our debt agreements would constitute default and would allow the lenders to accelerate the maturity of all indebtedness under the related agreement. If such acceleration were to occur, we would not have sufficient liquidity available to repay the indebtedness. We would likely have to seek amendments under the agreements for relief from the financial covenants or repay the debt with proceeds from the issuance of new debt or equity, and/or asset sales, if necessary. We may be unable to amend the agreements or raise sufficient capital to repay such obligations in the event the maturities are accelerated.

(1)

Adjusted EBITDA and Net Debt, which are non-GAAP measures used for these covenants, are calculated in accordance with the definition in the debt agreements. In this context, these measures are used solely to provide information on the extent to which we are in compliance with debt covenants and may not be comparable to adjusted EBITDA and Net Debt used by other companies. Reconciliations of adjusted EBITDA to net income and net debt to total debt are as follows:


	Twelve Months Ended June 30,		Twelve Months Ended September 30,
(DOLLARS IN MILLIONS)	2017		2017
Net income	$	395.3	$	415.8
Interest expense	55.8		61.9
Income taxes	102.0		109.5
Depreciation and amortization	108.3		112.5
Specified items ⁽¹⁾	89.0		71.8
Non-cash items ⁽²⁾	15.8		17.3
Adjusted EBITDA	$	766.2	$	788.8


(1)	Specified items for the 12 months ended ~~June~~September 30, 2017 of ~~$89.0~~$71.8 million consist of legal charges/credits, acquisition-related costs, costs associated with product recalls, operational improvement initiative costs, restructuring and other charges, gains on sales of fixed assets, integration-related costs, tax assessment and CTA realization.


(2)	Non-cash items represent all other adjustments to reconcile net income to net cash provided by operations as presented on the Statement of Cash Flows, including gain on disposal of assets and stock-based compensation.


	June 30,			September 30,
(DOLLARS IN MILLIONS)	2017			2017
Total debt	$	1,894.2		$	1,673.3
Adjustments:
Deferred gain on interest rate swaps	(0.4		)	(0.1		)
Cash and cash equivalents	(491.4		)	(316.0		)
Net debt	$	1,402.4		$	1,357.2

As discussed in Note 13 to the Consolidated Financial Statements, at ~~June~~September 30, 2017, we had entered into various guarantees and had undrawn outstanding letters of credit from financial institutions. These arrangements reflect ongoing business operations, including commercial commitments, and governmental requirements associated with audits or litigation that are in process with various jurisdictions. Based on the current facts and circumstances they are not reasonably likely to have a material impact on our consolidated financial condition, results of operations, or cash flows.

Cautionary Statement Under the Private Securities Litigation Reform Act of 1995

This Quarterly Report includes “forward-looking statements” under the Federal Private Securities Litigation Reform Act of 1995, including statements regarding (i) expected raw material costs in 2017, (ii) the expected impact of operational improvements, cost reduction efforts and mix enhancements on margins, (iii) the expected impact of the multi-year productivity program announced in 2017, (iv) cash flows to fund future operations and to meet debt service requirements, (v) the expected impact of the relocation of our Zhejiang Ingredients plant, and ~~(v)~~(vi) our plans and intentions to indefinitely reinvest undistributed foreign earnings in our foreign subsidiaries to fund local operations and/or capital projects. These forward-looking statements should be evaluated with consideration given to the many risks and uncertainties inherent in our business that could cause actual results and events to differ materially from those in the forward-looking statements. Certain of such forward-looking information may be identified by such terms as “will,” “expect,” “anticipate,” “believe,” “outlook,” “may,” “estimate,” “should,” “intend,” “plan” and “predict” similar terms or variations thereof. Such forward-looking statements are based on a series of expectations, assumptions, estimates and projections about the Company, are not guarantees of future results or performance, and involve significant risks, uncertainties and other factors, including assumptions and projections, for all forward periods. Our actual results may differ materially from any future results expressed or implied by such forward-looking statements. Such factors include, among others, the following:

macroeconomic trends affecting the emerging markets;

our ability to implement and adapt our Vision 2020 strategy;

our ability to successfully identify and complete acquisitions in line with our Vision 2020 strategy, and to realize the anticipated benefits of those acquisitions;

our ability to effectively compete in our market, and to successfully develop new and competitive products that appeal to our customers and consumers;

changes in consumer preferences and demand for our products or a decline in consumer confidence and spending;

our ability to benefit from our investments and expansion in emerging markets;

the impact of currency fluctuations or devaluations in the principal foreign markets in which we operate, including the devaluation of the Euro;

the impact of customer claims or product recalls;

the potential adverse impact of Brexit on currency exchange rates, global economic conditions and cross-border agreements that affect our business;

the economic and political risks associated with our international operations, including challenging economic conditions in China and Latin America;

the impact of any failure of our key information technology systems or costs that could be incurred due to a breach of data privacy or information security;

our ability to attract and retain talented employees;

our ability to comply with, and the costs associated with compliance, with U.S. and foreign environmental protection laws;

our ability to realize expected cost savings and efficiencies from our profitability improvement initiatives and other optimization activities;

volatility and increases in the price of raw materials, energy and transportation;

fluctuations in the quality and availability of raw materials;

the impact of a disruption in our supply chain or our relationship with our suppliers;

any adverse impact on the availability, effectiveness and cost of our hedging and risk management strategies;

our ability to successfully manage our working capital and inventory balances;

uncertainties regarding the outcome of, or funding requirements, related to litigation or settlement of pending litigation, uncertain tax positions or other contingencies;

the effect of legal and regulatory proceedings, as well as restrictions imposed on us, our operations, or our representatives by U.S. and foreign governments;

adverse changes in federal, state, local and international tax legislation or policies, including with respect to transfer pricing and state aid, and adverse results of tax audits, assessments, or disputes; and

changes in market conditions or governmental regulations relating to our pension and postretirement obligations.

New risks emerge from time to time and it is not possible for management to predict all such risk factors or to assess the impact of such risks on our business. Accordingly, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Any public statements or disclosures by the Company following this report that modify or impact any of the forward-looking statements contained in or accompanying this report will be deemed to modify or supersede such outlook or other forward-looking statements in or accompanying this report.

The foregoing list of important factors does not include all such factors, nor necessarily present them in order of importance. In addition, you should consult other disclosures made by the Company (such as in our other filings with the SEC or in company press releases) for other factors that may cause actual results to differ materially from those projected by the Company. Please refer to Part I. Item 1A., Risk Factors, of the 2016 Form 10-K for additional information regarding factors that could affect our results of operations, financial condition and cash flow.

Non-GAAP Financial Measures

The Company uses non-GAAP financial operating measures in this Quarterly Report, including: (i) currency neutral sales (which eliminates the effects that result from translating its international sales in U.S. dollars), (ii) adjusted gross margin (which excludes operational improvement initiative costs, acquisition-related costs, costs associated with product recalls and integration-related costs), (iii) adjusted operating profit and adjusted operating margin (which excludes legal charges/credits, acquisition-related costs, costs associated with product recalls, operational improvement initiative costs, restructuring and other charges, gains on sales of fixed assets, integration-related costs and tax assessments), (iv) adjusted selling and administrative expenses (which excludes acquisition-related costs, tax assessments, integration-related costs and legal charges/credits) and (v) adjusted effective tax rate (which excludes legal charges/credits, acquisition-related costs, costs associated with product recalls, operational improvement initiative costs, restructuring and other charges, gains on sales of fixed assets, integration-related costs, tax assessment and CTA realization). The Company also provides the non-GAAP measures adjusted EBITDA (which excludes certain specified items and non-cash items as set forth in the Company’s debt agreements) and net debt (which is adjusted for deferred gain on interest rate swaps and cash and cash equivalents) solely for the purpose of providing information on the extent to which the Company is in compliance with debt covenants contained in its debt agreements.

We provide these metrics because they are used by management as one means by which we assess our financial and operational performance and are also frequently used by analysts, investors and other interested parties in providing period to period comparisons of our operational performance. In addition, we believe that these measures, when used as supplements to GAAP measures of performance, are helpful to management and investors in evaluating the effectiveness of our business strategies and to compare our performance relative to our peers. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. Currency neutral sales, adjusted gross margin, adjusted operating profit, adjusted operating margin, adjusted selling and administrative expenses and adjusted effective tax rate should not be considered in isolation or as substitutes for analysis of our results under GAAP and may not be comparable to other companies’ calculation of such metrics.

A. Reconciliation of Non-GAAP Metrics

Three Months Ended ~~June~~September 30, 2017


(DOLLARS IN THOUSANDS)	Reconciliation of Gross Profit								Reconciliation of Gross Profit
	Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition and Related Costs (b)	Integration related costs (c)	FDA mandated product recall (h)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition and Related Costs (b)	Integration related costs (c)	Adjusted (Non-GAAP)
Gross profit	$	374,589	445	5,606	98	3,500	$	384,238	$	382,056	407	5,147	131	$	387,741


(DOLLARS IN THOUSANDS)	Reconciliation of Selling and Administrative Expenses											Reconciliation of Selling and Administrative Expenses
	Reported (GAAP)		Acquisition and Related Costs (b)		Integration related costs (c)		Legal Charges/Credits (d)		Tax Assessment (e)	Adjusted (Non-GAAP)		Reported (GAAP)		Acquisition and Related Costs (b)		Integration related costs (c)		Adjusted (Non-GAAP)
Selling and administrative expenses	$	135,910	(672	)	(542	)	(1,000	)	19	$	133,715	$	141,473	(289	)	(383	)	$	140,801


(DOLLARS IN THOUSANDS)	Reconciliation of Operating Profit														Reconciliation of Operating Profit
	Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Legal Charges/Credits (d)	Tax Assessment (e)		Restructuring and Other Charges (f)	Gain on Sale of Asset (g)		FDA mandated product recall (h)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Restructuring and Other Charges (d)	Gain on Sale of Asset (e)		Adjusted (Non-GAAP)
Operating profit	$	159,142	445	6,278	731	1,000	(19	)	791	(68	)	3,500	$	171,800	$	157,667	407	5,436	580	3,249	(31	)	$	167,308


(DOLLARS IN THOUSANDS)	Reconciliation of Net Income															Reconciliation of Net Income
	Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Legal Charges/Credits (d)	Tax Assessment (e)		Restructuring and Other Charges (f)		Gain on Sale of Asset (g)		FDA mandated product recall (h)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Restructuring and Other Charges (d)	Gain on Sale of Asset (e)		Adjusted (Non-GAAP)
Income before taxes	$	142,040	445	6,278	731	1,000	(19	)	791		(68	)	3,500	$	154,698	$	141,326	407	5,436	580	3,249	(31	)	$	150,967
Taxes on income ~~(i)~~(f)	$	32,245	111	1,472	243	354	(7	)	(75	)	(22	)	1,238	$	35,559	$	31,065	102	1,949	152	1,012	(10	)	$	34,270
Net income	$	109,795	334	4,806	488	646	(12	)	866		(46	)	2,262	$	119,139	$	110,261	305	3,487	428	2,237	(21	)	$	116,697

____________________

(a) Represents accelerated depreciation and idle labor costs in Hangzhou, China.

(b) Represents the amortization of inventory "step-up" related to the acquisitions of David Michael, Fragrance Resources and PowderPure, included in Cost of goods sold and transaction costs related to the acquisitions of David Michael, Fragrance Resources and PowderPure, included in Selling and administrative expenses.

(d) Represents ~~additional charge related to litigation settlement.~~

~~(e) Represents the reversal of a portion of the reserve for payment of a tax assessment related to commercial rent for prior periods.~~

~~(f) Represents~~ severance costs related to the 2017 Productivity ~~Program which were partially offset by the reversal of 2015 severance charges that were no longer needed.~~Program.

~~(g)~~(e) Represents gains on sale of assets.

(h) Represents an estimate of the Company's incremental direct costs and customer reimbursement obligations, in excess of the Company's sales value of the recalled products, arising from an FDA mandated recall of consumer products as a result of raw material received and identified by the Company as containing contamination. (As discussed in Note 13 of the Consolidated Financial Statements, the sales value of the recalled products was reserved in the first quarter of 2017). While the Company does not believe that any of the affected raw material was included in its finished products delivered to the customer, as the delivered product included raw material of the same vendor lot that tested positive, the FDA, after being notified by the Company, initiated a recall of all consumer products including raw material from the affected vendor lot due to the potential for product contamination.

~~(i)~~(f) The income tax expense (benefit) on non-GAAP adjustments is computed in accordance with ASC 740 using the same methodology as the GAAP provision of income taxes. Income tax effects of non-GAAP adjustments are calculated based on the applicable statutory tax rate for each jurisdiction in which such charges were incurred. For the ~~second~~third quarter of 2017, these non-GAAP adjustments were not subject to foreign tax credits or valuation allowances, but to the extent that such factors are applicable to any future non-GAAP adjustments we will take such factors into consideration in calculating the tax expense (benefit).

Three Months Ended ~~June~~September 30, 2016


(DOLLARS IN THOUSANDS)	Reconciliation of Gross Profit					Reconciliation of Gross Profit
	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Adjusted (Non-GAAP)	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Adjusted (Non-GAAP)
Gross profit	$	365,641	182	831	366,654	$	346,268	190	791	347,249


(DOLLARS IN THOUSANDS)	Reconciliation of Selling and Administrative Expenses						Reconciliation of Selling and Administrative Expenses
	Reported (GAAP)		Acquisition and Related Costs (c)		Legal Charges/Credits (d)	Adjusted (Non-GAAP)	Reported (GAAP)		Operational Improvement Initiative Costs (b)		Acquisition and Related Costs (c)		Legal Charges/Credits (d)		Adjusted (Non-GAAP)
Selling and administrative expenses	$	132,784	(213	)	36	132,607	$	152,046	(11	)	(786	)	(25,000	)	126,249


(DOLLARS IN THOUSANDS)	Reconciliation of Operating Profit										Reconciliation of Operating Profit
	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)		Gain on Sale of Asset (e)		Adjusted (Non-GAAP)	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)	Gain on Sale of Asset (e)		Adjusted (Non-GAAP)
Operating profit	$	164,672	182	831	213	(36	)	(197	)	165,665	$	124,426	190	802	786	25,000	(87	)	151,117


(DOLLARS IN THOUSANDS)	Reconciliation of Net Income												Reconciliation of Net Income
	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)		Legal Charges/Credits (d)		Gain on Sale of Asset (e)		Adjusted (Non-GAAP)		Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)	Gain on Sale of Asset (e)		Adjusted (Non-GAAP)
Income before taxes	$	152,050	182	831	213		(36	)	(197	)	$	153,043	$	113,390	190	802	786	25,000	(87	)	$	140,081
Taxes on income (f)	$	35,317	35	208	(102	)	(9	)	(65	)	$	35,384	$	23,613	36	200	276	8,750	(29	)	$	32,846
Net income	$	116,733	147	623	315		(27	)	(132	)	$	117,659	$	89,777	154	602	510	16,250	(58	)	$	107,235

____________________

(a) Accelerated depreciation related to restructuring activities.

(b) Accelerated depreciation and severance costs in Hangzhou, China.

(c) ~~Additional transaction~~Transaction costs related to the acquisition of ~~Lucas Meyer, included in Selling and administrative expenses.~~David Michael.

(d) ~~Principally~~Legal charge related to ~~favorable tax rulings.~~litigation accrual.

(e) Principally related to gain on sale of property in Europe.

(f) The income tax expense (benefit) on non-GAAP adjustments is computed in accordance with ASC 740 using the same methodology as the GAAP provision of income taxes. Income tax effects of non-GAAP adjustments are calculated based on the applicable statutory tax rate for each jurisdiction in which such charges were incurred. For the ~~second~~third quarter of 2016, these non-GAAP adjustments were not subject to foreign tax credits or valuation allowances, but to the extent that such factors are applicable to any future non-GAAP adjustments we will take such factors into consideration in calculating the tax expense (benefit).

~~Six~~Nine Months Ended ~~June~~September 30, 2017


(DOLLARS IN THOUSANDS)	Reconciliation of Gross Profit								Reconciliation of Gross Profit
	Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition and Related Costs (b)	Integration related costs (c)	FDA mandated product recall (i)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition and Related Costs (b)	Integration related costs (c)	FDA mandated product recall (i)	Adjusted (Non-GAAP)
Gross profit	$	739,255	1,066	10,908	186	3,500	$	754,915	$	1,121,311	1,473	16,055	316	3,500	$	1,142,655


(DOLLARS IN THOUSANDS)	Reconciliation of Selling and Administrative Expenses												Reconciliation of Selling and Administrative Expenses
	Reported (GAAP)		Acquisition and Related Costs (b)		Integration related costs (c)		Legal Charges/Credits (d)		Tax Assessment (e)		Adjusted (Non-GAAP)		Reported (GAAP)		Acquisition and Related Costs (b)		Integration related costs (c)		Legal Charges/Credits (d)		Tax Assessment (e)		Adjusted (Non-GAAP)
Selling and administrative expenses	$	276,240	(4,158	)	(1,485	)	(1,000	)	(5,331	)	$	264,266	$	417,713	(4,447	)	(1,867	)	(1,000	)	(5,331	)	$	405,068


(DOLLARS IN THOUSANDS)	Reconciliation of Operating Profit													Reconciliation of Operating Profit
	Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Legal Charges/Credits (d)	Tax Assessment (e)	Restructuring and Other Charges (f)	Gain on Sale of Asset (g)		FDA mandated product recall (i)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Legal Charges/Credits (d)	Tax Assessment (e)	Restructuring and Other Charges (f)	Gain on Sale of Asset (g)		FDA mandated product recall (i)	Adjusted (Non-GAAP)
Operating profit	$	296,578	1,066	15,066	1,923	1,000	5,331	10,934	(89	)	3,500	$	335,309	$	454,245	1,473	20,502	2,501	1,000	5,331	14,183	(120	)	3,500	$	502,615


(DOLLARS IN THOUSANDS)	Reconciliation of Net Income															Reconciliation of Net Income
	Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Legal Charges/Credits (d)	Tax Assessment (e)	Restructuring and Other Charges (f)	Gain on Sale of Asset (g)		CTA Realization (h)		FDA mandated product recall (i)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (a)	Acquisition Related Costs (b)	Integration related costs (c)	Legal Charges/Credits (d)	Tax Assessment (e)	Restructuring and Other Charges (f)	Gain on Sale of Asset (g)		CTA Realization (h)		FDA mandated product recall (i)	Adjusted (Non-GAAP)
Income before taxes	$	280,527	1,066	15,066	1,922	1,000	5,331	10,934	(89	)	(12,217	)	3,500	$	307,040	$	421,853	1,473	20,502	2,501	1,000	5,331	14,183	(120	)	(12,217	)	3,500	$	458,006
Taxes on income (j)	$	54,968	266	4,610	606	354	1,885	2,892	(29	)	—		1,238	$	66,790	$	86,033	368	6,559	757	354	1,885	3,904	(39	)	—		1,238	$	101,059
Net income	$	225,559	800	10,456	1,316	646	3,446	8,042	(60	)	(12,217	)	2,262	$	240,250	$	335,820	1,105	13,943	1,744	646	3,446	10,279	(81	)	(12,217	)	2,262	$	356,947

____________________

(a) Represents accelerated depreciation and idle labor costs in Hangzhou, China.

(d) Represents additional charge related to litigation settlement.

(e) Represents the reserve for payment of a tax assessment related to commercial rent for prior periods.

(f) Represents severance costs related to the 2017 Productivity Program which were partially offset by the reversal of 2015 severance charges that were no longer needed.

(g) Represents gains on sale of assets.

(h) Represents the release of CTA related to the liquidation of a foreign entity.

(i) Represents an estimate of the Company's incremental direct costs and customer reimbursement obligations, in excess of the Company's sales value of the recalled products, arising from an FDA mandated recall of consumer products as a result of raw material received and identified by the Company as containing contamination. (As discussed in Note 13 of the Consolidated Financial Statements, the sales value of the recalled products was reserved in the first quarter of 2017). While the Company does not believe that any of the affected raw material was included in its finished products delivered to the customer, as the delivered product included raw material of the same vendor lot that tested positive, the FDA, after being notified by the Company, initiated a recall of all consumer products including raw material from the affected vendor lot due to the potential for product contamination.

(j) The income tax expense (benefit) on non-GAAP adjustments is computed in accordance with ASC 740 using the same methodology as the GAAP provision of income taxes. Income tax effects of non-GAAP adjustments are calculated based on the applicable statutory tax rate for each jurisdiction in which such charges were incurred, except for those items which are non-taxable for which the tax expense (benefit) was calculated at 0%. For the first ~~six~~nine months of 2017, these non-GAAP adjustments were not subject to foreign tax credits or valuation allowances, but to the extent that such factors are applicable to any future non-GAAP adjustments we will take such factors into consideration in calculating the tax expense (benefit).

~~Six~~Nine Months Ended ~~June~~September 30, 2016


(DOLLARS IN THOUSANDS)	Reconciliation of Gross Profit						Reconciliation of Gross Profit
	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition and Related Costs (c)	Adjusted (Non-GAAP)	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition and Related Costs (c)	Adjusted (Non-GAAP)
Gross profit	$	725,849	283	1,099	889	728,120	$	1,072,117	473	1,890	889	1,075,369


(DOLLARS IN THOUSANDS)	Reconciliation of Selling and Administrative Expenses							Reconciliation of Selling and Administrative Expenses
	Reported (GAAP)		Acquisition and Related Costs (c)		Legal Charges/Credits (d)	Adjusted (Non-GAAP)		Reported (GAAP)		Operational Improvement Initiative Costs (b)		Acquisition and Related Costs (c)		Legal Charges/Credits (d)		Adjusted (Non-GAAP)
Selling and Administrative Expenses	$	256,327	(360	)	1,482	$	257,449	$	408,372	(11	)	(1,146	)	(23,518	)	$	383,697


(DOLLARS IN THOUSANDS)	Reconciliation of Operating Profit										Reconciliation of Operating Profit
	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)		Gain on Sale of Asset (e)		Adjusted (Non-GAAP)	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)	Gain on Sale of Asset (e)		Adjusted (Non-GAAP)
Operating profit	$	334,604	283	1,099	1,249	(1,482	)	(2,910	)	332,843	$	459,032	473	1,901	2,035	23,518	(2,998	)	483,961


(DOLLARS IN THOUSANDS)	Reconciliation of Net Income											Reconciliation of Net Income
	Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)		Gain on Sale of Asset (e)		Adjusted (Non-GAAP)		Reported (GAAP)		Restructuring and Other Charges (a)	Operational Improvement Initiative Costs (b)	Acquisition Related Costs (c)	Legal Charges/Credits (d)	Gain on Sale of Asset (e)		Adjusted (Non-GAAP)
Income before taxes	$	306,947	283	1,099	1,249	(1,482	)	(2,910	)	$	305,186	$	420,337	473	1,901	2,035	23,518	(2,998	)	$	445,266
Taxes on income (f)	$	71,610	54	275	266	(411	)	(637	)	$	71,157	$	95,223	90	475	542	8,339	(666	)	$	104,003
Net income	$	235,337	229	824	983	(1,071	)	(2,273	)	$	234,029	$	325,114	383	1,426	1,493	15,179	(2,332	)	$	341,263

____________________

(a) Accelerated depreciation related to restructuring activities.

(b) Accelerated depreciation and severance costs in Hangzhou, China.

(c) Expense related to the amortization of inventory step-up, included in Cost of goods sold, and additional transaction costs related to the ~~acquisition~~acquisitions of Lucas Meyer and David Michael, included in Selling and administrative expenses.

(d) ~~Settlements due~~Legal charges related to litigation accrual partially offset by a favorable tax rulings in jurisdictions for which reserves were previously recorded for ongoing tax disputes.

(e) Principally related to gain on sale of property in Europe.

(f) The income tax expense (benefit) on non-GAAP adjustments is computed in accordance with ASC 740 using the same methodology as the GAAP provision of income taxes. Income tax effects of non-GAAP adjustments are calculated based on the applicable statutory tax rate for each jurisdiction in which such charges were incurred. For the first ~~six~~nine months of 2016, these non-GAAP adjustments were not subject to foreign tax credits or valuation allowances, but to the extent that such factors are applicable to any future non-GAAP adjustments we will take such factors into consideration in calculating the tax expense (benefit).

B. Foreign Currency Reconciliation


	Three Months Ended June 30,			Six Months Ended June 30,		Three Months Ended September 30,		Nine Months Ended September 30,
	2017		2016	2017	2016	2017	2016	2017		2016
Operating Profit:
% Change - Reported (GAAP)	(3)%		11%	(11)%	7%	27%	(21)%	(1)%		(2)%
Items impacting comparability ⁽¹⁾	7%		(4)%	12%	(2)%	(16)%	13%	5%		3%
% Change - Adjusted (Non-GAAP)	4%		7%	1%	5%	11%	(8)%	4%		—%
Currency Impact	3%		—%	4%	2%	(4)%	4%	2%		3%
% Change Year-over-Year - Currency Neutral Adjusted (Non-GAAP)**	6%	*	7%	5%	7%	7%	(4)%	5%	*	3%

_______________________

(1) Includes ~~$12.7~~$9.6 million of acquisition-related costs, ~~costs associated with product recalls, legal charges,~~ restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets and ~~$1.0~~$26.7 million related to legal charges, operational improvement initiative, acquisition-relation and restructuring costs which were partially offset by gains on sales of fixed assets ~~and a favorable legal settlement~~ for the three months ended ~~June~~September 30, 2017 and ~~June~~September 30, 2016, respectively. Includes ~~$38.7~~$48.4 million consisting of acquisition-related costs, costs associated with product recalls, legal charges, tax assessment, restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets and excludes ~~a benefit~~charges of ~~$1.8~~$24.9 million related to ~~gains on sales of fixed assets and a favorable~~ legal ~~settlement, which were only partially offset by~~charges, acquisition-related, operational improvement initiative and restructuring costs which more than offset gains on sales of fixed assets for the ~~six~~nine months ended ~~June~~September 30, 2017 and ~~June~~September 30, 2016, respectively.

** Currency neutral amount is calculated by translating prior year amounts at the exchange rates used for the corresponding 2017 period. Currency neutral operating profit also eliminates the year-over-year impact of cash flow hedging.

* The sum of these items does not foot due to rounding.

C. Acquisition Related Intangible Asset Amortization

The Company tracks the amount of amortization recorded on recent acquisitions in order to monitor its progress with respect to its Vision 2020 goals. The following amounts were recorded with respect to recent acquisitions:


	Three Months Ended June 30,		Six Months Ended June 30,		Three Months Ended September 30,		Nine Months Ended September 30,
(DOLLARS IN MILLIONS)	2017	2016	2017	2016	2017	2016	2017	2016
Amortization Expense:
PowderPure	$0.6	$—	$0.6	$—	$0.6	$—	$1.2	$—
Fragrance Resources	1.5	—	2.8	—	1.6	—	4.4	—
David Michael	1.1	—	1.7	—	1.1	—	2.9	—
Lucas Meyer	1.9	1.7	3.8	4.3	2.0	2.0	5.8	6.3
Ottens Flavors	1.6	1.6	3.1	3.2	1.6	1.6	4.7	4.8

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There are no material changes in market risk from the information provided in our 2016 Form 10-K.

Item 4. Controls and Procedures

The Chief Executive Officer and Chief Financial Officer, with the assistance of other members of our management, have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

We have established controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosure.

The Chief Executive Officer and Chief Financial Officer have also concluded that there have not been any changes in our internal control over financial reporting during the quarter ended ~~June~~September 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We are subject to various claims and legal actions in the ordinary course of our business.

Environmental

Other

As previously disclosed, ~~in March 2012,~~we entered into a settlement agreement with ZoomEssence, Inc. filed a complaint against the Company in the U.S. District Court for the District of New Jersey alleging trade secret misappropriation, breach of contract and unjust enrichment in connection with certain spray dry technology disclosed to the Company. ZoomEssence sought an injunction and monetary damages. In November 2014, the Company filed a counterclaim against ZoomEssence alleging trade secret misappropriation, breach of contract, breach of the implied covenant of good faith and fair dealing, unjust enrichment, misappropriation of confidential and proprietary information, common law unfair competition, tortious interference with contractual relations, and conversion. During the second quarter of 2017, the Company and ZoomEssence mutually agreed to settle all claims and counterclaims. The parties agreed to dismiss their claims against one another, with prejudice and without any admission of liability or wrongful conduct, to avoid any further expense and disruption from the litigation. The complaint was dismissed, with prejudice, on July 5, 2017. Under the settlement agreement, the Company made a one-time payment to ZoomEssence of $56 million during the second quarter of 2017. For additional information on the matter, refer to Part I, Item 3 of our Annual Report filed on Form 10-K for the period ended December 31, 2016 and Part II, Item 1 of our Quarterly Reports on Forms 10-Q for the periods ended March 31, 2017 and ~~the parties exchanged full mutual releases. Accordingly, the Company recorded an additional charge of $1 million during the second quarter of~~June 30, 2017.

We are also a party to other litigations arising in the ordinary course of our business. We do not expect the outcome of these cases, singly or in the aggregate, to have a material effect on our consolidated financial condition.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

~~The table below reflects~~

Period
Total Number of
Shares
Repurchased ⁽¹⁾

Average
Price Paid
per Share

Total Number of
Shares Purchased as
Part of Publicly
Announced Program

Approximate Dollar Value
of Shares That May Yet
be Purchased Under the
Program
April 1 - 30, 2017 42,654 $133.63 42,654
$ 65,986,090
May 1 - 31, 2017 37,372 136.45 37,372
60,886,514
June 1 - 30, 2017 34,904 137.50 34,904
56,087,164
Total 114,930 $135.72 114,930
$ 56,087,164

~~(1)~~

Shares were repurchased pursuant to the repurchase program originally announced in December 2012 and amended in August 2015 (i) to increase from $250 million to $500 million the total purchase price of shares that may be repurchased under the program and (ii) to extend the program through December 31, 2017. Authorization of the repurchase program may be modified, suspended, or discontinued at any time.

Item 6. Exhibits



~~4.7~~3(ii)		~~Second Supplemental Indenture, dated as~~Bylaws of ~~May 18, 2017, among~~ International Flavors & Fragrances Inc. ~~and U.S. Bank National Association,~~, effective as ~~trustee (including the form~~ of ~~Notes),~~August 1, 2017, incorporated by reference to Exhibit ~~4.7~~3(ii) to the Registrant's Current Report on Form 8-K filed on ~~May 18,~~August 1, 2017.
12		Statement re: Computation of Ratios
31.1		Certification of Andreas Fibig pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Richard A. O'Leary pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32		Certification of Andreas Fibig and Richard A. O'Leary pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extensions Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase

~~SIGNATURES~~

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.~~

~~INTERNATIONAL FLAVORS & FRAGRANCES INC.~~



~~Dated:~~	~~August 8, 2017~~	~~By:~~	~~/s/ Andreas Fibig~~
			~~Andreas Fibig~~
			~~Chairman of the Board and Chief Executive Officer~~

~~Dated:~~	~~August 8, 2017~~	~~By:~~	~~/s/ Richard A. O'Leary~~
			~~Richard A. O'Leary~~
			~~Executive Vice President and Chief Financial Officer~~

EXHIBIT INDEX



Number		Description
12		Statement re: Computation of Ratios
31.1		Certification of Andreas Fibig pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Richard A. O'Leary pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32		Certification of Andreas Fibig and Richard A. O'Leary pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extensions Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase

43SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INTERNATIONAL FLAVORS & FRAGRANCES INC.



Dated:	November 6, 2017	By:	/s/ Andreas Fibig
			Andreas Fibig
			Chairman of the Board and Chief Executive Officer

Dated:	November 6, 2017	By:	/s/ Richard A. O'Leary
			Richard A. O'Leary
			Executive Vice President and Chief Financial Officer



Period	Total Number of Shares Repurchased ⁽¹⁾	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Program	Approximate Dollar Value of Shares That May Yet be Purchased Under the Program
April 1 - 30, 2017	42,654	$133.63	42,654	$	65,986,090
May 1 - 31, 2017	37,372	136.45	37,372	60,886,514
June 1 - 30, 2017	34,904	137.50	34,904	56,087,164
Total	114,930	$135.72	114,930	$	56,087,164